october 8-10 PFDWEEK THE VIRTUAL EXPERIENCE

conference Program

www.pfdweek.org Thank you to our Sponsors!

Platinum

TM an AbbVie company

Gold

Silver PFD Week 2020

Dear Colleagues, Get excited for PFD Week 2020 - The Virtual Experience! On behalf of the entire Program Committee, we are pleased to virtually welcome you to the 41st Annual Scientific Meeting, coming directly to the comfort of your living room, office, or wherever you choose to log in.

The scientific quality of the meeting is as strong as ever, we appreciate that you choose to submit and present your research at our annual meeting. In addition to the excellent abstracts, we have several speakers and panels focused on topics increasingly relevant to your practice and community, including our two keynote speakers. Khiara Bridges will speak on Racial Disparities, and David Mayer will speak on Creating a Culture of Safety. On Thursday night, join us for the Video Café - we will provide the movies, you bring the popcorn (or your snack of choice).

One of the hallmarks of a typical AUGS meeting is the ability to catch up with friends or have impromptu discussions with colleagues. Although a global pandemic has placed restrictions on our ability to meet in person this year, the Program Committee has planned several events to encourage interaction and discussion. To start each day, we will have an open “lobby” where meeting participants can join a free-flowing discussion on a predetermined topic moderated by subject matter experts. For example, on Wednesday morning we will have a session on pelvic anatomy moderated by Drs. DeLancey, Corton, and Kenton. On Saturday, we will have several concurrent sessions intentionally structured to encourage small group discussions.

We have also set aside time for fun! On Friday evening, we’ll come together for the AUGSome Karaoke Challenge, which is back this year. We look forward to hearing and seeing your creativity on display and encourage you to use this time to make your annual donation to the PFD Research Foundation. On Saturday afternoon, we have designated time for you to reconnect and catch up with friends and colleagues as we close out the meeting.

While I will miss the chance to connect in person, I look forward to spending PFD Week 2020 with you!!

PFD Week Program Committee Peter Jeppson, MD Committee Chair Peter Jeppson, MD Amanda White, MD Committee Vice-Chair PFD Week 2020 Program Chair Andrew Sokol, MD Workshop Chair Kimberly Ferrante, MD, MAS Workshop Vice-Chair

Chi Chiung Grace Chen, MD Sonia Dutta, MD Maria Florian-Rodriguez, MD Oz Harmanli, MD Saya Segal, MD, MSCE, FACOG Cheryl Simpson, RN, CNOR Table of contents

Continuing Education...... 4

Keynote Presentations...... 5

Schedule at a Glance...... 7

Thursday...... 7

Friday...... 7

Saturday...... 8

Award Recipients...... 25

Leadership...... 27

Invited Speaker Disclosure Guide...... 28

Meeting Code of Conduct education credits AUGS is committed to providing a safe, professional and productive meeting environment that fosters open dialogue and Category 1 Education Credits the exchange of scientific ideas, promotes equal opportunities Creighton University Health Sciences Continuing and treatment of all participants, supports diversity, and is free of Education designates this live activity for a maximum harassment and discrimination. of 15.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the Speakers are expected to demonstrate scientific integrity and extent of their participation in the activity. professional ethics. AUGS recognizes that professional and AAPA accepts AMA category 1 credit for the PRA well-intentioned scientists and clinicians can and do disagree; from organizations accredited by ACCME. PFD Week is intended to serve as a forum to consider and debate science-relevant viewpoints in an orderly, respectful, and fair manner. All participants are expected to treat others with respect NURSES CE and consideration and alert staff of any dangerous situations Creighton University Health Sciences Continuing or anyone in distress. This statement applies to all attendees, Education designates this activity for 15.5 contact speakers, exhibitors, staff, contractors, volunteers, and guests at hours for nurses. Nurses should claim only the the Annual Meeting and related events. credit commensurate with the extent of their participation in the activity. AUGS will not tolerate any form of harassment, sexual or otherwise. Harassment includes speech or behavior that is ACCREDITATION STATEMENT not welcome or is personally offensive, whether it is based on In support of improving ethnicity, gender, religion, age, body size, disability, veteran status, patient care, this activity marital status, sexual orientation, gender identity, or any other has been planned and reason not related to scientific merit. It includes stalking and implemented by Creighton University Health Sciences unwelcome attention. Behavior that is acceptable to one person Continuing Education (HSCE) and the American may not be acceptable to another, so use discretion to be sure Urogynecologic Society. Creighton University Health that respect is communicated. Harassment intended in a joking Sciences Continuing Education is jointly accredited manner still constitutes unacceptable behavior. Retaliation for by the Accreditation Council for Continuing Medical reporting harassment is also a violation of the Code of Conduct, Education (ACCME), the Accreditation Council for as is reporting an incident in bad faith. Harassment should be Pharmacy Education (ACPE), and the American Nurses reported immediately to an AUGS staff member through the virtual Credentialing Center (ANCC), to provide continuing meeting platform or at [email protected] or 301-273-0570. education for the healthcare team.

PFD Week 2020 4 ooCTCT 88 -- 1010 keynote Speakers and Lecturers keynote speakers and lecturers Raymond A. Lee Lecture: Advancing Women University of Michigan for Leadership in the advancement of and Underrepresented Minorities in OBGYN women and in 2015 she was recognized with the Life Time Achievement Award by the American Urogynecologic Society. THURSDAY, OCTOBER 8 1:30 PM – 2:05 PM Eastern | In 2017 she was the recipient of the prestigious Association Dee E. Fenner, MD of Professors of Gynecology and Obstetrics Lifetime Chair of the Department of Obstetrics and Achievement Award. Gynecology Bates Professor of Diseases of Women and The Raymond A. Lee Endowment is a named lectureship created Children by AUGS to honor one person annually who contributed to the University of Michigan development and surgical advancement of urogynecology and to further advance the knowledge and teaching of gynecologic Dee Fenner is the Chair of the Department of Obstetrics surgery through ongoing AUGS educational programs. and Gynecology and Bates Professor of Diseases of Women and Children at the University of Michigan. She holds a joint appointment as Professor of Urology. As a Missouri native, she attended undergraduate and medical school at the Keynote Lecture: Explaining Racial University of Missouri – Columbia. She completed a residency Disparities in Health: The Limitations of in Obstetrics and Gynecology at the University of Michigan Implicit Bias followed by a fellowship in Pelvic Reconstructive Surgery and Urogynecology at the Mayo Clinic-Scottsdale. Thursday, October 8 | 3:25 pm - 3:55 pm Eastern In 2001, Dr. Fenner returned to the University of Michigan Khiara M. Bridges, JD, PhD where she continues her work in female pelvic floor Professor of Law UC Berkeley School of Law dysfunction and medical education. She is nationally recognized as an expert in defecation disorders, surgical education, and reconstructive surgery. She has received research funds from the NIH and has served on several NIH Khiara M. Bridges is a professor of law at UC Berkeley study sections, organizing, and oversight committees. In School of Law. She has written many articles concerning addition, her research has been supported by private donors race, class, reproductive rights, and the intersection of the and industry. three. Her scholarship has appeared or will soon appear in Working with a multidisciplinary team, her major the Harvard Law Review, Stanford Law Review, the Columbia contributions have been on understanding how birth injuries Law Review, the California Law Review, the NYU Law Review, impact pelvic floor disorders and developing new and novel and the Virginia Law Review, among others. She is also the treatments for accidental bowel leakage. She has published author of three books: Reproducing Race: An Ethnography more than 100 peer-reviewed articles and chapters. of Pregnancy as a Site of Racialization (2011), The Poverty of Privacy Rights (2017), and Critical Race Theory: A Primer She is the Past-President of the Association of Professors of (2019). She is a coeditor of a reproductive justice book Obstetrics and Gynecology and the American Urogynecologic series that is published under the imprint of the University of Society. As Director of the Female Pelvic Medicine and California Press. Reconstructive Surgery Board for the American Board of Obstetrics and Gynecology and the American Board of She graduated as valedictorian from Spelman College, Urology, she was instrumental in obtaining official recognition receiving her degree in three years. She received her J.D. of the Female Pelvic Medicine and Reconstructive Surgery from Columbia Law School and her Ph.D., with distinction, from the American Board of Medical Subspecialties. Currently from Columbia University’s Department of Anthropology. she serves as Vice-President of the American Board of While in law school, she was a teaching assistant for the Obstetrics and Gynecology. former dean, David Leebron (Torts), as well as for the late E. Allan Farnsworth (Contracts). She was a member of the Dr. Fenner has received numerous awards for her Columbia Law Review and a Kent Scholar. She speaks fluent contributions as a physician surgeon, educator, and leader. Spanish and basic Arabic, and she is a classically trained Most notably, in 2011 she was awarded the “Continence ballet dancer. Champion” by the National Association for Continence, in 2014 she was given the Sarah Goddard Award by the

PFD Week 2020 5 oCT 8 - 10 keynote Speakers and Lecturers key not e sp a ke rs AUGS Innovation Lecture: Clinical Keynote Lecture: Creating a True Culture of Prediction Models, Machine Learning and Safety in a Large Health System Decision-Making friDAY, OCTOBER 9 | 1:30 PM – 2:00 PM Eastern friDAY, OCTOBER 9 | 10:00 AM – 10:35 AM Eastern David Mayer, MD J. Eric Jelovsek, MD, MMEd, MSDS Executive Director Associate Professor of Obstetrics and Gynecology MedStar Institute for Quality & Safety

and le ctur e rs Duke University School of Medicine

David Mayer, MD is executive director of the MedStar Institute J. Eric Jelovsek, MD, MMEd, MSDS is an Associate for Quality & Safety (MIQS). In this role, Dr. Mayer leads Professor of Obstetrics and Gynecology at Duke University specific quality and safety programs in support of discovery, School of Medicine in Durham, North Carolina where he learning, and the application of innovative methods to currently serves as Vice Chair for Education and Director operational clinical challenges. Dr. Mayer also serves as chief of the Women’s Health Data Science Program. Dr. Jelovsek executive officer for the Patient Safety Movement Foundation received his MD degree from East Tennessee State University, and on the Clinical Advisory Board for The Leap Frog Group. completed his residency in Obstetrics and Gynecology at Prior to this appointment Dr. Mayer served for over six years Duke University and fellowship in Female Pelvic Medicine as vice president, quality and safety for MedStar Health, and Reconstructive Surgery at Cleveland Clinic. He holds a overseeing the infrastructure for clinical quality and its Master’s degree in Medical Education with Distinction from operational efficiency for MedStar and each of its entities. the University of Dundee and a Master’s degree in Data Science from Northwestern University. Dr. Mayer joined MedStar from the University of Illinois Med- ical Center. Over the course of 10 years, he held numerous Dr. Jelovsek’s expertise lies in the development and validation roles including co-executive director of the UIC Institute for of “individualized,” patient-centered prediction tools to Patient Safety Excellence, director of UIC Masters of Science improve patient and clinician decision-making around a Patient Safety Leadership Program, associate dean for Educa- variety of women’s health conditions including: the risk of tion, and associate chief medical officer for Quality and Safety pelvic floor disorders after childbirth, predicting prolapse Graduate Medical Education. He served as vice chair for Qual- recurrence and utility change after undergoing pelvic organ ity and Safety for the Department of Anesthesiology, where he prolapse surgery, complications and health status after pelvic was an associate professor of Anesthesiology and director of organ prolapse surgery, risk of recurrent urinary incontinence Cardiac Anesthesiology. Dr. Mayer also founded and leads the and adverse events after mid-urethral sling placement, risk Annual Telluride International Patient Safety Roundtable and of de novo stress urinary incontinence after surgery for pelvic Patient Safety Medical Student Summer Camp. organ prolapse, and transfusion during gynecologic surgery. Dr. Jelovsek currently leads the clinical deployment of these Dr. Mayer attended the University of Illinois at Chicago for tools into the electronic medical record in the Department of both his undergraduate and medical degrees. He completed ObGyn at Duke. Dr. Jelovsek currently serves as co-principal his internship and residency at Michael Reese Hospital investigator in the NIDDK Symptoms of Lower Urinary Tract and Medical Center, followed by a fellowship in cardiac Dysfunction Research Network (LURN) and is involved in the anesthesia. He co-produced the patient safety educational study of unsupervised learning approaches such as clustering film series titled “The Faces of Medical Error…From Tears to of lower urinary tract phenotypes. He also serves as an Transparency,” which won numerous awards including the investigator in the NICHD Pelvic Floor Disorders Network and prestigious Aegis Film Society Top Short Documentary Award. as a mentor in the NIDDK-Duke KURe Program and NICHD Dr. Mayer has received many awards and honors throughout AUGS/DUKE UrogynCREST program. his career. Most recently, he was recognized and elected as a member of the International Society for Quality in The AUGS Innovation Lectureship Award honors an individual Health Care’s (ISQua) prestigious International Academy who has demonstrated innovation in urogynecology, specifically of Quality and Safety in Health Care (IAQS). He was listed demonstrating excellence in the development of new techniques (including diagnostic techniques), technology, outcome measures, on the Becker’s Hospital Review 2017 and 2018 lists of educational initiatives, product development or other activities that Top 50 people leading patient safety and was one of four support the goals of this Lectureship. medical professionals presented with the 2017 Humanitarian Award from the Patient Safety Movement Foundation for his lifesaving achievements in patient safety.

PFD Week 2020 6 oCT 8 - 10

SCHEDULE AT A GLANCE sc he du le atgl anc e a Thursday, OCTOBER 8 6:00 pm – 6:30 pm Industry Expert Theater: Monitoring Quality Improvement is the Path Forward Session I Presented by UroCure 9:30 AM – 10:00 am Pop in Lobby: Developing Surgical Skills Charles Rardin, MD, FACOG, FACS; Karen Through Residency, Fellowship, and into Richards Practice 6:30 pm – 7:00 pm Industry Expert Theater: InterStim Moderators: Charles Rardin, MD; Karolynn without Limits™: A Conversation with Echols, MD; Catherine A. Matthews, MD Experts Presented by Medtronic 9:30 AM – 10:00 am Pop in Lobby: Pelvic Anatomy Peter L. Rosenblatt, MD; Jennifer Klauschie, Moderators: John O. L. DeLancey, MD; Marlene MD; Nathan Johnson; Lauren Tran, PhD M. Corton, MD, MSCS; Kimberly Kenton, MD, MS VIDEO CAFÉ video café 10:00 AM – 10:15 am PFD Week 2020 – the Virtual Experience 7:00 PM – 7:30 pm Special Session: Perineal and Kick-off Vaginal Reconstruction Peter Jeppson, MD Erin Brown, MD 10:15 AM – 11:05 am Presidential Address and State of the Society 7:30 PM – 8:55 pm Video Café Shawn Menefee, MD 11:10 AM – 12:10 pm Abstracts (General Session I) 12:15 PM – 1:30 pm Expo Power Hour friDAY, OCTOBER 9 12:15 PM – 1:15 pm Industry Expert Theater: Live Robotic Sacrocolpopexy to Treat Post-Hysterectomy Session III Vault Prolapse Presented by Coloplast 8:00 AM – 9:00 Am Expo Power Hour Patrick Culligan, MD, FACOG, FACS; 9:00 AM – 9:30 am Pop in Lobby: Business Strategies to Peter L. Rosenblatt, MD, FACOG Build a Practice SESSION II Session II Moderators: Ryan R. Stratford, MD, MBA; 1:15 PM – 1:25 pm FPMRS Journal Update Mitchell W. Schuster, MD; Beri Ridgeway, MD Linda Brubaker, MD, MS 9:30 AM – 10:00 am Pop in Lobby: Building a Research Infrastructure and Career 1:30 PM – 2:05 pm Raymond A. Lee Lecture: Advancing Women and Underrepresented Minorities in OBGYN Moderators: Vivian W. Sung, MD, MPH; Leslee Subak, MD; Emily S. Lukacz, MD, MAS Dee E. Fenner, MD 9:15 AM – 9:30 am Mini State-of-the-Art Lectures 2:10 PM – 3:20 pm Abstracts (General Session II) 9:35 AM – 9:50 am Mini State-of-the-Art Lectures 3:25 PM – 3:55 pm Keynote Address: Explaining Racial Disparities in Health: The Limitations of 10:00 AM – 10:35 am AUGS Innovation Lecture: Clinical Implicit Bias Prediction Models, Machine Learning Khiara M. Bridges, JD, PhD and Decision-Making J. Eric Jelovsek, MD, MMEd, MSDS 4:00 PM – 7:00 pm Expo Power Hour / Listen and Learn 10:40 AM – 11:50 am Abstracts (General Session III) 4:00 pm – 4:30 pm Industry Expert Theater Presented by Memic 11:55 AM – 12:25 pm Panel: Integrating Sexual Medicine into 4:30 pm – 4:45 pm Industry Expert Theater Presented by Laborie your Urogynecology Practice 5:30 pm – 6:00 pm Industry Expert Theater: Innovative Solutions Cheryl B. Iglesia, MD; Rachel Rubin, MD by NEOMEDIC: ANCHORSURE SSLF Device 12:30 PM – 1:30 pm Expo Power Hour and REMEEX Lifetime Adjustable Sling Presented by Neomedic International Catherine Matthews, MD; Costas Apostolis, MD

PFD Week 2020 7 oCT 8 - 10 Workshops require a separate registration fee. Pre-ConferenSCHEDULE AT Ac GLANCe WorkshoE ps Please visit the registration desk to inquire.

12:30 PM – 1:30 pm Industry Expert Theater: Solyx™ saturday , OCTOBER 10 schedule atglance a Single-Incision Sling: Why You Should Consider It for Your Patients Session V Presented by Boston Scientific 9:30 AM – 10:00 am P op in Lobby: Strategies for Developing Kevin Benson, MD, FPMRS Successful Mentoring Relationships SESSION IV Session IV Moderators: Elizabeth Mueller, MD; Joseph Schaffer, MD; Miles Murphy, MD, MSPH 1:30 PM – 2:00 pm Keynote Address: Creating a True Culture 9:30 AM – 10:00 am P op in Lobby: Tips and Tricks from the of Safety in a Large Health System Editors: Manuscript Submissions and David Mayer, MD Peer-reviews 2:05 PM – 3:05 pm Abstracts (General Session IV - A) Moderators: Rebecca G. Rogers, MD; 2:05 PM – 3:30 pm Abstracts (General Session IV - B) Catherine S. Bradley, MD, MSCE; W. Thomas 3:10 PM – 3:40 pm Special Session: The Current State of Gregory, MD Neuromodulation in Urogynecology 10:00 AM – 10:35 am P anel: Microbiome: How is it Used in Felicia L. Lane, MD; Brooke Gurland, MD Urogynecology? With the Bladder, Vagina, or Rectum 3:10 Pm – 3:40 Pm Special Session: Vulvovaginal Pain Disorders – How to Intervene A. Lenore Ackerman, MD, PhD; Yuko M. Komesu, MD; Holly E. Richter, PhD, MD Hope Haefner, MD 10:40 AM – 11:50 am Abstracts 4:00 PM – 7:00 pm Expo Power Hour / Listen and Learn (General Session V – Basic Science) 4:00 PM – 5:00 pm Fellowship Program Meet-and-Greet 11:55 am – 12:05 pm Introduction for Afternoon Sessions for Residents 12:00 PM – 1:30 pm Expo Power Hour 4:00 pm – 4:15 pm Industry Expert Theater Presented by Laborie 12:00 PM – 1:00 pm Industry Expert Theater: Changing the 5:00 pm – 6:00 pm Industr y Expert Theater: Advanced Paradigm in the Management of SUI – Insights Into Third-Line OAB Therapy Presented by Contura Vincent Lucente, MD; Roger Dmochowski, Presented by Allergan MD, MMHC, FACS; Tomi Mikkola, MD; Andrea Eman Elkadry, MD Pezzella, MD 6:30 pm – 7:00 pm Industr y Expert Theater: Improve SESSION VI Session VI Patient Experience and Engagement by Integrating Social Media into your Practice 1:10 PM – 1:25 pm PFD Research Foundation Update Presented by Caldera Christopher Tarnay, MD Laura Burden, BBA 1:30 PM – 1:40 pm Introductions 1:40 PM – 2:40 pm Concurrent Short Oral Sessions AUGS SOCIAL EVENTAUGS Social event 2:30 PM – 3:30 PM Pop in Lobby: Reflections and Takeaways 7:00 PM – 9:00 pm AUGSome Karaoke Challenge – from the Meeting Benefiting the PFD Research oundationF Moderators: Christina Lewicky-Gaupp, MD; Anthony G. Visco, MD; Sangeeta Mahajan, MD

SESSION VII Session VII 3:00 PM – 3:10 pm Introductions 3:15 PM – 4:15 pm Concurrent Short Oral Sessions

PFD Week 2020 8 oCT 8 - 10 Workshops require a separate registration fee. ThurSDAY, OCTOBER 8 Please visit the registration desk to inquire.

Session I 11:10 am - 12:10 pm

General Session I 9:30 am – 10:00 am Moderators: Deborah L. Myers, MD; Francisco Orejuela, MD, MS Pop in Lobby: Developing Surgical Skills 11:10 am - 11:20 am Through Residency, Fellowship, and into Best Overall Paper Long Oral 1 - Concomitant Practice Retropubic Midurethral Sling and Moderators: Charles Rardin, MD; Karolynn Echols, MD; OnabotulinumtoxinA Injections are a Safe Treatment Catherine A. Matthews, MD Option for Mixed Urinary Incontinence A. Komar1, C. E. Bretschneider2, M. G. Mueller1, C. Lewicky-Gaupp1, S. A. Collins1, J. Geynisman-Tan1, M. Tavathia1 and K. Kenton1. 1Chicago, IL, 2Winfield, OH 9:30 am – 10:00 am 11:20 am - 11:30 am Pop in Lobby: Pelvic Anatomy Best Clinical Paper Long Oral 2 - Success and Failure Moderators: John O. L. DeLancey, MD; Marlene M. Corton, MD, are Dynamic, Recurrent Event States that Alternate after Surgical Treatment for Pelvic Organ Prolapse MSCS; Kimberly Kenton, MD, MS J. E. Jelovsek1, M. D. Barber1, M. G. Gantz2, A. Sridhar3, E. S. Lukacz4, H. M. Zyczynski5, H. S. Harvie6, G. C. Dunivan7, J. Schaffer8, V. W. Sung9, R. E. Varner Jr.10 and D. Mazloomdoost11. 1Durham, NC, 2Asheville, NC, 3Research Triangle Park, NC, 4La Jolla, CA, 5Pittsburgh, PA, 6Flourtown, PA, 7Albuquerque, 10:00 am -10:15 am NM, 8Dallas, TX, 9Providence, RI, 10Birmingham, AL, 11Rockville, MD

PFD Week 2020 – The Virtual Experience 11:30 am - 11:40 am Kick-off Long Oral 3 - Subgroups of Failure after Surgery Speaker: Peter Jeppson, MD for Pelvic Organ Prolapse and their Association with Outcomes: A Longitudinal Cluster Analysis J. E. Jelovsek1, M. D. Barber1, R. Chew2, M. G. Gantz3, C. Kery1, A. Sridhar2, E. S. Lukacz4, H. M. Zyczynski5, G. C. Dunivan6, H. S. Harvie7, J. Schaffer8, V. 10:15 am - 11:05 am W. Sung9, R. E. Varner Jr.10 and D. Mazloomdoost11. 1Durham, NC, 2Research Triangle Park, NC, 3Asheville, NC, 4La Jolla, CA, 5Pittsburgh, PA, 6Albuquerque, Presidential Address and State of the Society NM, 7Flourtown, PA, 8Dallas, TX, 9Providence, RI, 10Birmingham, AL, 11Rockville, MD Speaker: Shawn Menefee, MD 11:40 am - 11:50 am Long Oral 4 - A Randomized Trial Comparing Neuromodulation with Percutaneous Tibial Nerve Stimulation to Sham Treatment for Accidental Bowel Leakage – The NOTABLe Trial H. M. Zyczynski. Pittsburgh, PA, H. E. Richter. Birmingham, AL, V. W. Sung. Providence, RI, E. S. Lukacz. La Jolla, CA, L. A. Arya. Philadelphia, PA, D. D. Rahn. Dallas, TX, B. Carper. Research Triangle Park, NC, A. G. Visco. Durham, NC, D. Mazloomdoost. Rockville, MD and M. G. Gantz. Asheville, NC

11:50 am - 12:00 pm Long Oral 5 - Surgical Outcomes in UroGynecology- Assessment of Peri- and Postoperative Complications Relative to Preoperative Hemoglobin A1c (SUGAR study) N. E. Ringel1, K. L. Barnes2, M. Siddique3, T. D. Marczak4, C. K. Kisby5, E. C. Rutledge6, A. J. Soriano7, P. A. Samimi8, M. Schroeder7, S. J. Handler9 and R. E. Gutman10. 1Washington, DC, 2Long Beach, CA, 3Providence, RI, 4Brighton, MA, 5Rochester, MN, 6Houston, TX, 7Philadelphia, PA, 8Nashville, TN, 9Torrance, CA, 10Bethesda, MD

12:00 pm - 12:10 pm Long Oral 6 - Development of a Patient-Centered Pelvic Floor Complication Scale J. J. Fitzgerald. Pittsburgh, PA, H. E. Richter. Birmingham, AL, G. C. Dunivan. Albuquerque, NM, V. W. Sung. Providence, RI, R. E. Gutman. Bethesda, MD and M. Mete. Hyattsville, MD

PFD Week 2020 9 oCT 8 - 10 Thursday, October 8

12:15 pm - 1:30 pm 2:30 pm - 2:40 pm Long Oral 8 - Fluids Affecting Bladder Urgency Expo Power Hour Visit and explore the and Lower Urinary Symptoms (FABULUS): Results virtual exhibit hall from a Randomized Controlled Trial M. O. Schimpf, A. R. Smith, K. Hawthorne, C. Garcia and J. M. Miller. Ann Arbor, MI 12:15 pm - 1:15 pm 2:40 pm - 2:50 pm Industry Expert Theater: Live Robotic Long Oral 9 - Randomized Controlled Trial of Sacrocolpopexy to Treat Post-Hysterectomy Gabapentin versus Placebo for Postoperative Pain after Sacrospinous Ligament Fixation for Pelvic Vault Prolapse Presented by Coloplast Organ Prolapse Patrick Culligan, MD, FACOG, FACS; Peter L. Rosenblatt, MD, FACO J. M. Wu1, A. A. Dieter2, K. Feliciano1, A. Connolly1, E. J. Geller1 and M. G. Willis-Gray3. 1Chapel Hill, NC, 2Chevy Chase, MD, 3Durham, NC

Session II 2:50 pm - 3:00 pm Long Oral 10 - A Randomized Controlled Trial of 1:15 pm - 1:25 pm Clobetasol Propionate Versus Fractionated CO2 Laser for the Treatment of Lichen Sclerosus – FPMRS Journal Update Twelve Month Follow Up and Crossover Outcomes (eCuRLS) Speaker: Linda Brubaker, MD, MS M. Siddique. Providence, RI, L. S. Burkett. Pittsburgh, PA, A. Zeymo. Hyattsville, MD, R. E. Gutman. Bethesda, MD, A. Park. Cleveland, OH and C. B. Iglesia. Washington, DC

1:30 pm - 2:05 pm 3:00 pm - 3:10 pm Raymond A. Lee Lecture: Advancing Women Long Oral 11 - Trajectories of Pelvic Floor Symptoms Following Vaginal Delivery in and Underrepresented Minorities in OBGYN Primiparas Women between Third Trimester and 1 Moderator: Shawn Menefee, MD year Postpartum 1 1 2 1 1 Speaker: Dee E. Fenner, MD A. J. Hill , J. Yang , L. I. Martinez , I. Nygaard and M. J. Egger. Salt Lake City, UT, 2Salt Lake CIty, UT

3:10 pm - 3:20 pm 2:10 pm - 3:20 pm Long Oral 12 - Nitrofurantoin Administration for the Prevention of Short-Term Catheter Associated General Session II Urinary Tract Infection After Pelvic Surgery (NAUTICA): A Randomized Controlled Trial Moderators: Candace Parker-Autry, MD; Robert E. Gutman, MD D. Bastawros1, K. Kaczmarski2, J. Zhao2, R. Bender2, E. M. Myers2 and M. E. Tarr3. 1Clemmons, NC, 2Charlotte, NC, 3Concord, NC 2:10 pm - 2:20 pm Best Video Video 2 - Laparoscopic Repair of Persistent Vesicovaginal Fistula: Importance of Proper Identification in Cases of Recurrence 3:25 pm - 3:55 pm T. D. Marczak. Brighton, MA, W. D. Winkelman. Brookline, MA and P. L. Rosenblatt. Cambridge, MA Keynote Lecture: Explaining Racial Disparities in Health: The Limitations of 2:20 pm - 2:30 pm Implicit Bias Basic Science PhD Award Long Oral 7 - Vaginal Angulation after Vaginal Hysterectomy with Uterosacral Moderator: Gena Dunivan, MD Ligament Suspension or Vaginal Mesh Hysteropexy: Speaker: Khiara M. Bridges, JD, PhD Investigating the Role of Vaginal Configuration in Anatomic Failure of Apical Prolapse Repair S. T. Bowen1, P. A. Moalli1, S. D. Abramowitch1, M. Lockhart2, A. C. Weidner3, C. A. Ferrando4, H. E. Richter2, C. R. Rardin5, Y. M. Komesu6, H. S. Harvie7, 4:00 pm - 7:00 pm C. W. Nager8, D. Mazloomdoost9, A. Sridhar10 and M. G. Gantz11. 1Pittsburgh, PA, 2Birmingham, AL, 3Durham, NC, 4Cleveland, OH, 5Providence, RI, Expo Power Hour Visit and explore the 6Albuquerque, NM, 7Flourtown, PA, 8La Jolla, CA, 9Rockville, MD, 10Research virtual exhibit hall Triangle Park, NC, 11Asheville, NC Listen and Learn Visit the poster sessions and watch on-demand content

PFD Week 2020 10 oCT 8 - 10 Thursday, October 8

4:00 pm - 4:30 pm 7:30 pm - 8:55 pm

Industry Expert Theater Presented by Memic Video Café Moderators: Sunil Balgobin, MD; Tirsit Asfaw, MD

4:30 pm - 4:45 pm 7:30 pm - 7:39 pm Industry Expert Theater Presented by Laborie Video 4 - Ureteroneocystostomy and Psoas Hitch for Ureteral Injury Sustained during Cesarean Section W. R. Smith. Winston Salem, NC and C. A. Matthews. Winston-Salem, NC

5:30 pm - 6:00 pm 7:39 pm - 7:48 pm Industry Expert Theater: Innovative Video 5 - Native Tissue Sacrospinous Hysteropexy from an Anterior Approach Solutions by NEOMEDIC: ANCHORSURE A. Plair and C. A. Matthews. Winston-Salem, NC SSLF Device and REMEEX Lifetime Adjustable Sling Presented by Neomedic International 7:48 pm - 7:58 pm Catherine Matthews, MD; Costas Apostolis, MD Video 6 - Combined Supra and Submeatal Approach to Excision of Complex Mid-Urethral Sling Mesh Erosion 6:00 pm - 6:30 pm E. C. Rutledge, S. P. Desai, R. Sosland and R. Khavari. Houston, TX

Industry Expert Theater: Monitoring 7:58 pm - 8:08 pm Quality Improvement is the Path Forward Video 7 - Obstructed Defecation Syndrome: A Novel Presented by UroCure Diagnostic Algorithm J. B. Pincus1, G. Rostami Nia1 and R. P. Goldberg2. 1Chicago, IL, 2Skokie, IL Charles Rardin, MD, FACOG, FACS; Karen Richards 8:08 pm - 8:15 pm Video 8 - Application of a Custom 3D Vaginal Model 6:30 pm - 7:00 pm for Sacrocolpopexy Surgical Simulation A. Melnyk, J. C. Sassani, D. Sinex, P. A. Moalli, S. D. Abramowitch and M. Industry Expert Theater: InterStim without J. Bonidie. Pittsburgh, PA Limits™: A Conversation with Experts 8:15 pm - 8:25 pm Presented by Medtronic Video 9 - A Simulation Model for LeFort Colpocleisis Peter L. Rosenblatt, MD; Jennifer Klauschie, MD; Nathan Johnson; R. Raju, C. K. Kisby and J. A. Occhino. Rochester, MN Lauren Tran, PhD 8:25 pm - 8:35 pm video café Video 10 - Anatomical Anomalies in Sacrocolpopexy Surgery M. G. Mueller1, S. A. Collins1, A. Abdeen2, K. Kenton1, P. J. Culligan3 and D. 7:00 pm - 7:30 pm Glazier4. 1Chicago, IL, 2Richmond, VA, 3New York, NY, 4Midlothian, VA

Perineal and Vaginal Reconstruction 8:35 pm - 8:45 pm Moderator: Brittany Star Hampton, MD Video 11 - Sacral Neuromodulation: Sacral Anatomy Speaker: Erin Brown, MD and Optimal Lead Placement W. K. Hendrickson and C. L. Amundsen. Durham, NC

8:45 pm - 8:54 pm Video 12 - Vesicouterine Fistula: A Robotic Approach M. V. Baker, C. K. Kisby and J. A. Occhino. Rochester, MN

PFD Week 2020 11 oCT 8 - 10 Wednesday, October 10 friDAY, OCTOBER 9

Session III 9:35 am - 9:50 am

Mini State-of-the-Art Lectures 8:00 Am - 9:00 Am Current Status and Recommendations Expo Power Hour Regarding the Use of Vaginal Lasers Visit and explore the virtual exhibit hall Moderator: Tyler M. Muffly, MD, FACS Speaker: Eric R. Sokol, MD Currently Available Imaging for Pelvic Floor Disorders 9:00 am - 9:30 am Moderator: Gina M. Northington, MD, PhD Speaker: Milena M. Weinstein, MD Pop in Lobby: Business Strategies to Build a Practice Evaluation and Treatment of Pelvic Floor Hypertonicity Moderators: Ryan R. Stratford, MD, MBA; Moderator: Christine A. LaSala, MD Mitchell W. Schuster, MD; Beri Ridgeway, MD Speaker: Uchenna Ossai, PT, DPT, WCS Ureteral Location at the Time of Repair of 9:30 am - 10:00 am Latrongenic Bladder Injury Moderator: John Occhino, MD Pop in Lobby: Building a Research Speaker: David Glazier, MD Infrastructure and Career What is the Current Evidence Regarding the Moderators: Vivian W. Sung, MD, MPH; Leslee Subak, MD; Evaluation and Management of Defecatory Emily S. Lukacz, MD, MAS Dysfunction Caused by Bowel Outlet Obstruction? Moderator: Mallika Anand, MD Speaker: Cara L. Grimes, MD, MAS 9:15 am - 9:30 am 10:00 am - 10:35 am Mini State-of-the-Art Lectures Hematuria: What Should We Be Doing? AUGS Innovation Lecture: Clinical Moderator: Cara S. Ninivaggio, MD Prediction Models, Machine Learning Speaker: Oz Harmanli, MD and Decision-making How Does the Pelvic Floor Change After Moderator: Holly Richter, MD Childbirth and What Can Be Done About It? Speaker: J. Eric Jelovsek, MD, MMEd, MSDS Moderator: Cassandra Carberry, MD, MS Speaker: Joan L. Blomquist, MD Responsible Innovation in an Age of Intense 10:40 am - 11:50 am Scrutiny – Considerations for Patients and Investigators General Session III Moderator: Amy Park, MD Moderators: Allison M. Wyman, MD; Shawn Menefee, MD Speaker: Samantha J. Pulliam, MD 10:40 am - 10:50 am Updates on OAB Pharmacotherapy Video 3 - Combined Vaginal and Obturator Dissection Moderator: Matthew Barker, MD for Complete Removal of Mini-Sling, Partial Removal Speaker:Leslie Rickey, MD, MPH of Transobturator Sling, and Excision of Sinus Tract K. C. McDonald1, Z. LaPier2, D. L. O’Shaughnessy2 and P. S. Finamore3. What is our Understanding of Pelvic Organ 1Manhasset, NY, 2Bayshore, NY, 3Bay Shore, NY Prolapse Based on Basic Science Research? 10:50 am - 11:00 am Moderator: Heidi S. Harvie, MD, MSCE, MBA Speaker: Marianna Alperin, MD, MS Long Oral 13 - Tamsulosin Versus Placebo to Prevent Postoperative Urinary Retention Following Female Pelvic Reconstructive Surgery: A Multicenter Randomized Controlled Trial G. C. Chapman, D. Sheyn, E. Slopnick, K. Roberts, J. W. Henderson IV, S. A. El-Nashar, J. Mangel, A. Hijaz, R. Pollard and S. T. Mahajan. Cleveland, OH

PFD Week 2020 12 oCT 8 - 10 friday, October 9

11:00 am - 11:10 am Session IV Long Oral 14 - Microbiome Predictors of Surgical Treatment Response in Women Undergoing Mid-Urethral 1:30 pm - 2:00 pm Sling Surgery for Mixed Urinary Incontinence H. E. Richter1, M. Carnes2, Y. M. Komesu3, E. S. Lukacz4, R. G. Rogers5, N. Y. Keynote Lecture: Creating a True Culture of Siddiqui2, L. A. Arya6, V. W. Sung7, M. S. Bradley8, B. Carper9, D. Mazloom- Safety in a Large Health System doost10, D. L. Dinwiddie3 and M. G. Gantz11. 1Birmingham, AL, 2Durham, NC, 3Albuquerque, NM, 4La Jolla, CA, 5Albany, NY, 6Philadelphia, PA, 7Providence, RI, Moderator: Sylvia Botros-Brey, MD 8Pittsburgh, PA, 9Research Triangle Park, NC, 10Rockville, MD, 11Asheville, NC Speaker: David Mayer, MD

11:10 am - 11:20 am Long Oral 15 - A Prospective, Randomized Trial 2:05 pm - 3:05 pm Comparing Intravesical Dimethyl Sulfoxide (DMSO) to Bupivacaine, Triamcinolone, and Heparin (BTH), General Session IV - A for Newly Diagnosed Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS) Moderators: Blair B. Washington, MD, MHA; Jonathan P. N. P. Moss1, P. K. Sand2, C. Chang3, S. Botros-Brey4, J. E. Tomezsko1, R. P. Shepherd, MD, MSc Goldberg1 and A. Gafni-Kane5. 1Skokie, IL, 2Winnetka, IL, 3Evanston, IL, 4San Antonio, TX, 5Chicago, IL 2:05 pm - 2:15 pm Best Resident Paper 11:20 am - 11:30 am Long Oral 19 - Outcomes Following Total Vaginal Hysterectomy with Long Oral 17 - How Does the Urethra Respond to Uterosacral Ligament Suspension Compared to Bladder Filling in Continent and Incontinent Women? Supracervical Hysterectomy with Sacrocervicopexy J. Geynisman-Tan, T. Mou, M. G. Mueller and K. Kenton. Chicago, IL for the Management of Uterovaginal Prolapse L. E. Giugale1, A. Melnyk1, K. M. Ruppert2, G. S. Napoe3, E. S. Lavelle1 and 11:30 am - 11:40 am M. S. Bradley1. 1Pittsburgh, PA, 2Pgh, PA, 3Providence, RI Long Oral 18 - Maybe Incontinence is Just Incontinence: Urethral Function and Urodynamic Parameters between 2:15 pm - 2:25 pm Urgency and Stress Incontinence do not Differ Long Oral 20 - Patient Preparedness for Pelvic Organ J. Geynisman-Tan, T. Mou and K. Kenton. Chicago, IL Prolapse Surgery: A Randomized Controlled Trial of Preoperative Counseling 11:40 am - 11:50 am J. C. Sassani1, P. J. Grosse1, L. Kunkle, L. Baranski1 and M. F. Ackenbom1. 1 Latebreaking Abstract - Vaginal Surgery for Pittsburgh, PA Uterovaginal Prolapse: 5 Year Results of a Randomized Trial of Vaginal Mesh Hysteropexy vs Vaginal 2:25 pm - 2:35 pm Hysterectomy with Uterosacral Ligament Suspension Best Urogynecology Fellow Paper Long Oral 21 - Home Bio- C. W. Nager1, A. G. Visco2, H. E. Richter3, C. R. Rardin4, Y. M. Komesu5, H. S. feedback versus Pelvic Floor Physical Therapy for Stress 6 7 8 9 10 Harvie , H. M. Zyczynski , M. F. R. Paraiso , D. Mazloomdoost , A. Sridhar Urinary Incontinence: A Randomized, Non-Inferiority Trial and S. Thomas10. 1 2 3 4 La Jolla, CA, Durham, NC, Birmingham, AL, Providence, L. Barnes1, S. B. Cichowski2, Y. M. Komesu1, P. C. Jeppson1, C. S. Ninivaggio1, RI, 5Albuquerque, NM, 6Flourtown, PA, 7Pittsburgh, PA, 8Cleveland, OH, B. L. McGuire1 and G. C. Dunivan1. 1Albuquerque, NM, 2Portland, OR 9Rockville, MD, 10Research Triangle Park, NC 2:35 pm - 2:45 pm 11:55 am - 12:25 pm Long Oral 22 - Surgical Management of Symptomatic Apical Pelvic Organ Prolapse: A Systematic Review Panel: Integrating Sexual Medicine and Meta-Analysis into Your Urogynecology Practice M. Larouche. Dorval, QC, Canada, E. Belzile. Montreal, QC, Canada and R. Geoffrion. West Vancouver, BC, Canada Moderator: Danielle D. Antosh, MD Speakers: Cheryl B. Iglesia, MD; Rachel Rubin, MD 2:45 pm - 2:55 pm Long Oral 24 - A Prospective Randomized Trial Comparing Restorelle® Y Mesh and Dual Flat 12:30 pm - 1:30 pm Mesh for Laparoscopic and Robotic-Assisted Expo Power Hour Visit and explore the Sacrocolpopexy: 24-month Outcomes virtual exhibit hall C. A. Ferrando and M. F. R. Paraiso. Cleveland, OH 2:55 pm - 3:05 pm 12:30 pm - 1:30 pm Long Oral 26 - Pain after Permanent versus Delayed- Absorbable Monofilament Suture for Vaginal Industry Expert Theater: Solyx™ Single- Graft Attachment During Minimally-Invasive Total Incision Sling: Why You Should Consider It Hysterectomy and Sacrocolpopexy (PACT) for Your Patients Presented by Boston Scientific C. E. Bretschneider1, K. Kenton2, J. M. Wu3, E. J. Geller3 and C. A. Matthews4. 1Winfield, OH, 2Chicago, IL, 3Chapel Hill, NC, 4Winston-Salem, NC Speaker: Kevin Benson, MD, FPMRS

PFD Week 2020 13 oCT 8 - 10 Workshops require a separate registration fee. Pre-Conferenfriday, Octobecre 9Workshops Please visit the registration desk to inquire.

2:05 pm - 3:05 pm 3:10 pm - 3:40 pm General Session IV - B Vulvovaginal Pain Disorders – Moderators: Cedric K. Olivera, MD, MS, FACOG, FACS, FPMRS; How to Intervene Megan O. Schimpf, MD Moderator: Elisa R. Trowbridge, MD Speaker: Hope Haefner, MD 2:05 pm - 2:15 pm Long Oral 25 - High-Resolution Characterization of the Intramuscular Extracellular Matrix across 4:00 pm - 7:00 pm Non-Pregnant to Postpartum Continuum in the Rat Model Expo Power Hour Visit and explore the L. A. Burnett1, P. Duran2, M. Maslanka3, K. C. Weldon1, K. C. Hansen3, K. L. virtual exhibit hall Christman2 and M. Alperin2. 1San Diego, CA, 2La Jolla, CA, 3Aurora, CO Listen and Learn Visit the poster sessions 2:15 pm - 2:25 pm and watch on-demand content Long Oral 27 - Exosome-Induced Vaginal Tissue Regeneration in a Porcine Mesh Exposure Model: A Follow-up Dosing and Chronicity Study 4:00 pm - 5:00 pm C. K. Kisby, I. Y. Shadrin, A. Behfar, P. Stalboerger, E. C. Trabuco and J. A. Occhino. Rochester, MN Fellowship Program Meet-and-Greet for Residents 2:25 pm - 2:35 pm Long Oral 28 - Expanded Quantitative Urine Culture Improves Outcomes in Women Symptomatic for UTI 4:00 pm - 4:15 pm who have a non-E. coli Urotype O. M. Abdel-Rahim1, H. C. Barnes2, T. M. Halverson3, B. J. Wolff2, E. E. Hilt3, Industry Expert Theater Presented by Laborie A. T. Harrington3, B. R. Hochstedler3, T. T. Pham3, M. G. Acevedo Alvarez3, P. C. Schreckenberger3, C. J. Joyce3, C. Fitzgerald3, E. R. Mueller3 and A. J. Wolfe3. 1Forest Park, IL, 2Oak Park, IL, 3Maywood, IL 5:30 pm - 6:00 pm 2:35 pm - 2:45 pm Industry Expert Theater: Advanced Insights Long Oral 29 - Induction of Cellular Senescence in Vaginal Fibroblasts and Treatment with Senolytics: An Into Third-Line OAB Therapy Presented by Allergan In Vitro Model for the Study of Pelvic Organ Prolapse Eman Elkadry, MD M. E. Florian Rodriguez, A. M. Hare, K. Yau, N. G. Gaddam, P. W. Keller, H. Shi and R. A. Word. Dallas, TX

2:45 pm - 2:55 pm 6:30 pm - 7:00 pm Long Oral 30 - Impact of Vaginal Distention on Cell Industry Expert Theater: Improve Patient Senescence in an Animal Model of Pelvic Organ Experience and Engagement by Integrating Prolapse (POP) A. M. Hare, N. G. Gaddam, H. Shi, J. F. Acevedo, M. E. Florian Rodriguez and Social Media into your Practice Presented by Caldera R. A. Word. Dallas, TX Laura Burden, BBA

2:55 pm - 3:05 pm Long Oral 23 - Purified Exosome Product Cell-free AUGS Social event Regenerative Platform Restores Urethral Pressures in the Porcine SUI Model 7:00 pm - 9:00 pm E. C. Trabuco, T. Rolland, P. Stalboerger and A. Behfar. Rochester, MN AUGSome Karaoke Challenge – Benefiting the PFD Research Foundation 3:10 pm - 3:40 pm The Current State of Neuromodulation in Urogynecology Moderator: David D. Rahn, MD Speakers: Felicia L. Lane, MD; Brooke Gurland, MD

PFD Week 2020 14 oCT 8 - 10 Wednesday, October 10 saturDAY, OCTOBER 10 Scientific Salons Grand Ballroom CD 11:00 am - 11:10 am Session V Long Oral 33 - Altered Mesh Geometry: A Pathway to Reproducible Mesh Complications In Vivo K. M. Knight, R. Liang, G. E. King, S. L. Palcsey, S. D. Abramowitch and P. A. 9:30 am - 10:00 am Moalli. Pittsburgh, PA

Pop in Lobby: Strategies for Developing 11:10 am - 11:20 am Successful Mentoring Relationships Long Oral 34 - Brain Derived Neurotrophic Factor Moderators: Elizabeth Mueller, MD; Joseph Schaffer, MD; Mediates Pudendal Nerve Regeneration Accelerated with Electrical Stimulation in an Animal Model of Miles Murphy, MD, MSPH Stress Urinary Incontinence B. Balog1, K. Deng1, T. Askew1, T. Fabiyi2, B. Hanzlicek1 and M. S. Damaser1. 1Cleveland, OH, 2Santa Cruz, CA 9:30 am - 10:00 am 11:20 am - 11:30 am Pop in Lobby: Tips and Tricks from the Long Oral 35 - Evaluating Immunomodulatory Editors - Manuscript Submissions and Biomaterials in a Rabbit Model of Lumbar Colpopexy Peer-reviews M. Therriault, A. Iftikhar, C. Skillen, K. M. Knight, P. A. Moalli, S. D. Abramowitch and B. N. Brown. Pittsburgh, PA Moderators: Rebecca G. Rogers, MD; Catherine S. Bradley, MD, MSCE; W. Thomas Gregory, MD 11:30 am - 11:40 am Long Oral 36 - Purified Exosome Product Cell-Free Regenerative Platform to Repair Volumetric Muscle 10:00 am - 10:35 am Loss in the Rat Model E. C. Trabuco, R. Takhter, T. Rolland, P. Stalboerger, S. Boroumand and A. Panel: Microbiome: How is it Used in Behfar. Rochester, MN Urogynecology? With the Bladder, Vagina, 11:40 am - 11:50 am or Rectum Long Oral 37 - Load-induced Sarcomerogenesis Moderator: Linda Brubaker, MD, MS Alters the Physiological Limits of the Pelvic Floor Speakers: A. Lenore Ackerman, MD, PhD; Yuko M. Komesu, MD; Muscles in the Pre-Clinical Rat Model Holly E. Richter, PhD, MD M. M. Rieger1, F. Boscolo Sesillo1, L. A. Burnett2 and M. Alperin1. 1La Jolla, CA, 2San Diego, CA

10:40 am - 11:50 am 11:55 am - 12:05 pm General Session V (Basic Science) Introduction for Afternoon Sessions Moderators: Lieschen H. Quiroz, MD; Heidi W. Brown, MD, MAS Speaker: Peter Jeppson, MD 10:40 am - 10:50 am Long Oral 31 - Randomized Trial of Standard versus Expanded Cultures to Diagnose UTI in Women’s 12:00 pm - 1:30 pm Catheterized Urine Samples H. C. Barnes1, B. J. Wolff1, A. T. Harrington2, E. E. Hilt2, T. M. Halverson2, O. Expo Power Hour Visit and explore the M. Abdel-Rahim3, B. R. Hochstedler2, T. T. Pham2, M. G. Acevedo Alvarez2, virtual exhibit hall C. J. Joyce2, C. Fitzgerald2, P. C. Schreckenberger2, A. J. Wolfe2 and E. R. Mueller2. 1Oak Park, IL, 2Maywood, IL, 3Forest Park, IL

10:50 am - 11:00 am 12:00 pm - 1:00 pm Best Basic Science Paper Long Oral 32 - Understanding Industry Expert Theater: Changing the the In Vivo Impact of Pore Geometry on the Biomechanical Properties of the Vagina Paradigm in the Management of SUI K. M. Knight, D. Sinex, G. E. King, S. L. Palcsey, S. D. Abramowitch and P. A. Presented by Contura Moalli. Pittsburgh, PA Speakers: Vincent Lucente, MD; Roger Dmochowski, MD, MMHC, FACS; Tomi Mikkola, MD; Andrea Pezzella, MD

PFD Week 2020 15 oCT 8 - 10 saturday, October 10

Session VI 2:30 pm - 2:40 pm Short Oral 6 - Can Pharmacogenetics be Used 1:10 pm - 1:25 pm to Predict Cognitive Changes with Fesoterodine Fumarate? PFD Research Foundation Update E. J. Geller1, T. Wiltshire1, K. Schmader2 and J. M. Wu1. 1Chapel Hill, NC, 2Hillsborough, NC Speaker: Christopher Tarnay, MD

1:40 pm - 2:40 pm 1:30 pm - 1:40 pm Short Oral Session (UUI 2) Introductions Moderators: Tajnoos Yazdany, MD; Marian G. Acevedo Alvarez, MD

1:40 pm - 1:50 pm 1:40 pm - 2:40 pm Short Oral 7 - Interim Effectiveness of a Coin- sized Tibial Nerve Stimulator for Urgency Urinary Short Oral Session (UUI) Incontinence in a TENS Responder Cohort at 36 weeks Moderators: Susan Barr, MD; Amanda B. White, MD K. L. Ferrante. La Jolla, CA, J. Lukban. Englewood, CO, B. Kaaki. Waterloo, IA, T. P. Giudice. Columbia, SC, J. N. Nguyen. Downey, CA, A. Rogers. Santa 1:40 pm - 1:50 pm Barbara, CA, R. J. McCrery. Omaha, NE, S. MacDiarmid. Greensboro, NC, A. Shapiro. Owings Mills, MD, S. Serels. Norwalk, CT, C. B. Threatt. Redwood Short Oral 1 - Comparative Analysis of Pain Scores City, CA, J. Kaminetsky. New York, NY, J. Gauta. Naples, FL, V. Lucente. Among Differing Analgesic Regimens for Women Allentown, PA, S. Dutta. Wilmette, IL and P. K. Sand. Winnetka, IL Undergoing In-Office OnabotulinumtoxinA Injection for Idiopathic Overactive Bladder 1:50 pm - 2:00 pm T. S. Pratt1, M. Merchant and O. Ramm1. 1Oakland, CA Short Oral 8 - Brain Activation Changes in Response to OnabotulinumtoxinA Treatment of Urgency 1:50 pm - 2:00 pm Urinary Incontinence Short Oral 2 - The Effect of Stress Urinary B. Clarkson1, C. J. Chermansky1, A. Wei1, S. Tyagi1, H. Karim1, D. Griffiths2 Incontinence in Women with Mixed Urinary and N. Resnick1. 1Pittsburgh, PA, 2Edmonton, AB, Canada Incontinence on Catheterization Rates Following Intradetrusor OnabotulinumtoxinA Injection: Benefit 2:00 pm - 2:10 pm or Burden? Short Oral 9 - Prevalence of Childhood Trauma and C. Brandon1, D. Glass2, C. Oh3, F. Kreines1, S. Thakker1, B. M. Brucker1, N. its Association with Lower Urinary Tract Symptoms Rosenblum4, V. W. Nitti5 and D. Malacarne Pape1. 1New York, NY, 2Chicago, IL, 3New york, NY, 4Chappaqua, NY, 5Los Angeles, CA in Women and Men J. Geynisman-Tan1, M. E. Helmuth2, A. R. Smith2, C. S. Bradley3, C. L. 4 5 1 1 2 3 2:00 pm - 2:10 pm Amundsen , K. Flynn and M. G. Mueller . Chicago, IL, Ann Arbor, MI, Iowa City, IA, 4Durham, NC, 5Milwaukee, WI Short Oral 3 - Reduction in Incontinence Product Use and Associated Cost Savings After 2:10 pm - 2:20 pm OnabotulinumtoxinA Treatment in Patients With Overactive Bladder Short Oral 10 - Heightened Bladder Sensation in Response to the Sight or Sound of Running Water M. F. Lorenzo-Gomez. Salamanca, Spain, H. Schulte-Baukloh. Berlin, Identified in Individuals with Overactive Bladder Germany, E. Farrelly. Stockholm, Sweden, A. Boroujerdi. Irvine, CA and R. 1 1 1 3 Hamid. London, United Kingdom L. Siff , U. Sivagnanalingam, P. Koirala, K. Maddra , R. Li , K. Egenberger , S. Roberts1, N. Swavely1, D. Meyer1, S. Weprin1, L. Stothers4, A. W. Carroll1, J. E. Speich1 and A. P. Klausner1. 1Richmond, VA, 2Waterbury, CT, 3Vancouver, 2:10 pm - 2:20 pm BC, Canada Short Oral 4 - Cost-Effectiveness Analysis of Mirabegron vs Anticholinergic for Initial Medical 2:20 pm - 2:30 pm Therapy of Overactive Bladder Accounting for Risk of Dementia Short Oral 11 - Where I Go Mobile Application: Development and Pilot Evaluation of a New B. S. St Martin1, S. L. Wallace2, K. Lee1, A. Park3 and E. R. Sokol1. 1Stanford, Bladder Tool for Assessing the Role of Individual CA, 2Moreland Hills, OH, 3Cleveland, OH Environmental Factors on a Woman’s Decision to Void E. R. Mueller1, Y. Sheng2, M. D. Lavender3, A. D. Markland4, J. F. Wyman5, 2:20 pm - 2:30 pm S. Sutcliffe6, D. Shoham1, L. Rickey7, C. Cain8, H. Chu5, L. C. An2 and J. Short Oral 5 - Overactive Bladder Medication: M. Miller2. 1Maywood, IL, 2Ann Arbor, MI, 3Chicago, IL, 4Birmingham, AL, Anticholinergics vs Mirabegron by Specialty 5Minneapolis, MN, 6Saint Louis, MO, 7New Haven, CT, 8Woodbury, MN A. A. Sripad, C. Raker and V. W. Sung. Providence, RI

PFD Week 2020 16 oCT 8 - 10 saturday, October 10

2:30 pm - 2:40 pm 1:40 pm - 2:40 pm Short Oral 12 - Overactive Bladder and the Social Determinants of Health Short Oral Session (Defecatory Dysfunction L. M. Tellechea1, S. W. Zuo2, J. Kohn3, H. Roberts3, G. Chen3, M. Fazzari2, and Rectal Prolapse) A. Leegant4, M. A. Laudano2 and N. Abraham2. 1Fort Lee, NJ, 2Bronx, NY, 3Baltimore, MD, 4New York, NY Moderators: Douglass S. Hale, MD; Taylor Brueseke, MD

1:40 pm - 1:50 pm 1:40 pm - 2:40 pm Short Oral 43 - Rectocele: Correlation Between Defecography and Physical Examination Short Oral Session (Pregnancy and PFDs) C. Crowder. Orange, CA, N. Sayegh. Irvine, CA, S. E. Jeney. Costa Mesa, CA, K. Buono. Sacramento, CA, J. Yao. Pasadena, CA, E. L. Whitcomb. Newport Moderators: Ralph Chesson, MD; Andrew I. Sokol, MD Beach, CA and N. M. Guaderrama. Dana Point, CA

1:40 pm - 1:50 pm 1:50 pm - 2:00 pm Short Oral 31 - Predicting Risk of Obstetric Anal Short Oral 44 - Efficacy and Safety of a Non-Animal Sphincter Injuries at the Time of Admission for Labor Stabilized Hyaluronic Acid/Dextranomer (NASHA/ A. R. Meekins1, C. Zhao2, N. Y. Siddiqui2, C. Grotegut2, B. Alhanti2 and J. E. Dx FI [Solesta®]) in Improving Fecal Incontinence: A Jelovsek2. 1Hillsborough, NC, 2Durham, NC Prospective, Single-Arm, Multicenter, Clinical study with 36-Month Follow-up 1:50 pm - 2:00 pm L. H. Quiroz1, D. E. Galliano Jr.2, G. Da Silva, S. A. Shobeiri4, M. A. Nihira5, L. C. Pan6, E. Bromley6, J. Hinahara6 and T. F. Goss6. 1Oklahoma City, OK, 2Port Short Oral 32 - Pelvic Pain and Psychological Well- Charlotte, FL, 3Falls Church, VA, 4Riverside, CA, 5Boston, MA Being in Women Following Obstetric Anal Sphincter Injury 2:00 pm - 2:10 pm C. E. Painter. San Francisco, CA and O. Ramm. Oakland, CA Short Oral 45 - The Relationship Between Frailty and 2:00 pm - 2:10 pm Defecatory Distress in a Diverse Patient Population S. W. Zuo1, J. Kohn2, L. M. Tellechea3, A. Leegant4, P. K. K. Halani5, C. C. G. Short Oral 33 - Effect of Second Pregnancy and Mode Chen2 and M. A. Laudano1. 1Bronx, NY, 2Baltimore, MD, 3Fort Lee, NJ, 4New of Delivery on the Prevalence of Symptomatic Pelvic York, NY, 5New Rochelle, NY Floor Disorders - Longitudinal Study S. Ondrová1, L. Hympanova2, K. Grohregin3, M. Krcmar4, L. Krofta3 and J. 2:10 pm - 2:20 pm Feyereisl5. 1Prague, 101, Czech Republic, 2Praha, 101, Czech Republic, 3Prague, Czech Republic, 4Prague 4, 101, Czech Republic, 5Prague 4, Czech Short Oral 46 - Evaluation of Mobile Applications for Republic Patients with Fecal Incontinence Using a Modified APPLICATIONS Scoring System 2:10 pm - 2:20 pm M. Vega1, E. R. Mckay1 and P. K. Halani2. 1Bronx, NY, 2New Rochelle, NY Short Oral 34 - Urethral Morphology Changes with Pregnancy 2:20 pm - 2:30 pm M. S. Cramer1, E. Boniface2, A. Holland2 and W. T. Gregory2. 1Vancouver, WA, Short Oral 47 - Comparison of 30-Day Postoperative 2Portland, OR Complications Between Rectal Prolapse Only Surgical Patients and Combined Rectal Prolapse and 2:20 pm - 2:30 pm Pelvic Organ Prolapse Surgical Patients S. L. Wallace1, E. Enemchukwu2, K. Mishra3, L. Neshatian3, A. Orakzai3, B. Short Oral 35 - Does Vaginal Birth Cause Changes in H. Chen2, L. Rogo-Gupta4, E. R. Sokol2 and B. H. Gurland2. 1Moreland Hills, Perineal Membrane Morphology? OH, 2Stanford, CA, 3Redwood City, CA, 4Palo Alto, CA F. Pipitone, C. W. Swenson, J. O. L. DeLancey and L. Chen. Ann Arbor, MI 2:30 pm - 2:40 pm 2:30 pm - 2:40 pm Short Oral 48 - Comparison of Rectal Prolapse Short Oral 36 - Musculoskeletal Findings on MRI Recurrence Rates Between Rectal Prolapse Only Among Postpartum Women with Persistent Pelvic Pain Surgical Patients and Combined Rectal Prolapse and F. Pipitone, M. E. Duarte Thibault, K. Gaetke-Udager, D. E. Fenner and C. W. Pelvic Organ Prolapse Surgical Patients Swenson. Ann Arbor, MI S. L. Wallace1, K. Mishra2, E. Enemchukwu3, L. Neshatian2, A. Orakzai2, B. H. Chen3, L. Rogo-Gupta4, E. R. Sokol3 and B. Gurland3. 1Moreland Hills, OH, 2Redwood City, CA, 3Stanford, CA, 4Palo Alto, CA

PFD Week 2020 17 oCT 8 - 10 Workshops require a separate registration fee. Pre-Conferensaturday, Octocebe Workshor 10 ps Please visit the registration desk to inquire.

1:40 pm - 2:40 pm 1:40 pm - 2:40 pm

Short Oral Session (Surgical Treatment Short Oral Session (Clinical Potpourri and of SUI) Racial Disparity) Moderators: Amy E. Rosenman, MD; Sonia Dutta, MD Moderators: Charles W. Nager, MD; Jill Danford, MD

1:40 pm - 1:50 pm 1:40 pm - 1:50 pm Short Oral 61 - Biomechanical Properties of Short Oral 67 1 Mobile Health Preferences and Permanent and Fully Resorbable Mid-Urethral Sling Text-Messaging Response Rates for Urogynecologic Mesh at 3, 9 and 18-months Following Implantation in Research: A Survey Study and Pilot Text-Messaging a Rabbit Model Program D. El-Neemany1, D. O’shaughnessy2, D. Grande3, A. Wong3, S. Sajjan4, C. M. Dahl. Los Angeles, CA and C. E. Dancz. Alhambra, CA Jin3, D. Shalom2, L. Lind2 and H. Winkler5. 1Bergenfield, NJ,2 Great Neck, NY, 3Manhasset, NY, 4NYC, NY, 5Hempstead, NY 1:50 pm - 2:00 pm 1:50 pm - 2:00 pm Short Oral 68 - Cost-Effectiveness of Group-Based Pelvic Floor Muscle Training Compared to Standard Short Oral 62 - A Randomized Control Study on Timing Individual Pelvic Floor Muscle Training for Treating of Mid-Urethral Sling During Concomitant Prolapse Urinary Incontinence in Women age 60 and Over Surgery: Before or After Apical Suspension? C. Dumoulin1, L. Pazzoto Cacciari1, C. Kouakou2, M. Morin2, M. Tousignant2, M. Vega1, S. Solouki2, D. Carlos and A. Leegant2. 1Bronx, NY, 2New York, NY L. Vale3, M. H. Mayrand4 and T. Poder1. 1Montreal, QC, Canada, 2Sherbrooke, QC, Canada, 3Newcastle upon Tyne, England, United Kingdom, 4Monteal, 2:00 pm - 2:10 pm QC, Canada Short Oral 63 - Success of Concomitant vs. Interval 2:00 pm - 2:10 pm Mid-Urethral Slings for Prevention and Treatment of Bothersome De Novo SUI Short Oral 69 - The First Wearable Uroflowmeter J. J. Fitzgerald1, A. J. Soriano2, J. Panza3, T. P. Hoke4, S. P. Desai5, A. M. with Physical Activity Recognition Artsen1, D. D. Antosh5 and R. E. Gutman6. 1Pittsburgh, PA, 2Philadelphia, PA, A. Attari, J. O. L. DeLancey and J. A. Ashton-Miller. Ann Arbor, MI 3Nashville, TN, 4Homewood, AL, 5Houston, TX, 6Bethesda, MD 2:10 pm - 2:20 pm 2:10 pm - 2:20 pm Short Oral 70 - Patient-Centered Outcomes Short Oral 64 - Medical Center Volume and following CO2 Vaginal Laser for The Treatment of Reoperation Risk After Mid-Urethral Sling Genitourinary Syndrome of Menopause A. Berger, J. Tan-Kim and S. Menefee. San Diego, CA V. Casas-Puig, M. F. R. Paraiso, R. Farrell and C. A. Ferrando. Cleveland, OH

2:20 pm - 2:30 pm 2:20 pm - 2:30 pm Short Oral 65 - Incidence of Mid-Urethral Sling Short Oral 71 - Disparity of Racial/Ethnic Revision or Removal in Relation to its Timing with Representation in Publications Contributing to Surgery for Pelvic Organ Prolapse Overactive Bladder (OAB) Diagnosis and Treatment S. S. Boyd, J. Long, E. Agbese and D. Leslie. Hershey, PA Guidelines O. Brown1, M. Siddique2, T. Mou1, E. Boniface3, K. A. Volpe4 and S. B. 2:30 pm - 2:40 pm Cichowski3. 1Chicago, IL, 2Providence, RI, 3Portland, OR, 4Los Angeles, CA Short Oral 66 - Seven-year Outcomes of Bulkamid Injections for the Treatment of Stress-Predominant 2:30 pm - 2:40 pm Urinary Incontinence Short Oral 72 - Community-Based Research Increases A. Kuhn. Berne, Switzerland, E. R. Sokol. Stanford, CA, K. Lobodasch. Participation Among Older Minority Women with Changsha, China and T. Brosche. Chemniz, Germany Urinary Incontinence S. Pearson1, L. Temple1, T. Bishop2, A. Ukaegbu1, J. Alden1, J. Kwagyan1 and T. V. Sanses3. 1Washington, DC, 2Hyattsville, MD, 3Baltimore, MD

PFD Week 2020 18 oCT 8 - 10 saturday, October 10

1:40 pm - 2:40 pm 1:40 pm - 2:40 pm

Short Oral Session (PreOp ERAS) Short Oral Session (Intra and Postop Bladder Moderators: Mikio Nihira, MD; Saya Segal, MD, MSCE, FACOG Evaluation) Moderators: Matthew D. Barber, MD, MHS; Christopher Chung, MD 1:40 pm - 1:50 pm Short Oral 73 - Impact of Postoperative Activity 1:40 pm - 1:50 pm Restriction on Activity, Pain and Quality of Life in Short Oral 79 - Postoperative Voiding Function After Women Undergoing Reconstructive Pelvic Surgery Implementation of a Pelvic Reconstructive Surgery- (RPS) for Pelvic Organ Prolapse (POP) Specific Enhanced Recovery After Surgery (ERAS) M. G. Mueller1, J. Geynisman-Tan1, S. A. Collins1, C. Lewicky-Gaupp1, C. E. Pathway 2 1 1 2 Bretschneider and K. Kenton . Chicago, IL, Winfield, OH S. Evans1, E. Yelverton2, K. Kaczmarski2, O. Abimbola3, M. E. Tarr4 and E. M. Myers2. 1Roanoke, VA, 2Charlotte, NC, 3Greensboro, NC, 4Concord, NC 1:50 pm - 2:00 pm Short Oral 74 - IMACTIV: A Pilot Study of the IMpact 1:50 pm - 2:00 pm of Unrestricted ACTIVity Following Urethral Sling Short Oral 80 - Is it Worth the Cost? A Cost Benefit Surgery Analysis of Postoperative Post-Void Residual L. N. Tholemeier1, E. Choi2, C. Bresee2, F. F. Kanji2, A. L. Ackerman2, J. T. Bladder Scan Thresholds 3 2 1 2 3 Anger and K. S. Eilber . Los Anglees, CA, Los Angeles, CA, Sherman S. M. Jansen1, A. Woll2, S. E. Swift2 and C. A. Heisler3. 1Madison, WI, Oaks, CA 2Charleston, SC, 3Cross Plains, WI

2:00 pm - 2:10 pm 2:00 pm - 2:10 pm Short Oral 75 - The Influence of Patients’ Goals on Short Oral 81 - Risk Factors for Urinary Retention Surgical Satisfaction after Urogynecologic Surgery: A Retrospective A. Gillingham1, S. A. Collins1, K. Kenton1, C. E. Bretschneider2, C. Lewicky- Cohort Study and Prediction Model 1 1 1 1 1 Gaupp , M. G. Mueller , O. Brown , T. Mou and J. Geynisman-Tan . B. Y. Zhang1, J. M. H. Wong1, N. A. Koenig1, T. Lee1 and R. Geoffrion2. 1 2 Chicago, IL, Winfield, OH 1Vancouver, BC, Canada, 2West Vancouver, BC, Canada

2:10 pm - 2:20 pm 2:10 pm - 2:20 pm Short Oral 76 - Is Patient Satisfaction Correlated Short Oral 82 - Post-Operative Urinary Retention with Long-Term Anatomical Outcomes Following Management: A Cost Analysis Native Tissue Prolapse Repair? R. Wang. Hartford, CT and E. Tunitsky. West Hartford, CT P. Schmidt, L. Chen, J. O. L. DeLancey and C. W. Swenson. Ann Arbor, MI 2:20 pm - 2:30 pm 2:20 pm - 2:30 pm Short Oral 83 - Is There a Best Way to Perform a Short Oral 78 - A Randomized Control Trial Postoperative Void Trial After Benign Gynecologic Evaluating Preoperative Telephone Calls on Surgical and Urogynecologic Surgery? A Systematic Review Preparedness in Urogynecology 1 2 3 4 2 1 1 2 1 2 A. A. Dieter , J. L. Conklin , M. G. Willis-Gray , S. Desai , M. Grant and G. E. Halder , A. B. White , H. W. Brown , L. Caldwell , D. L. Giles , C. A. M. S. Bradley5. 1 2 3 4 3 1 4 1 2 3 Chevy Chase, MD, Chapel Hill, NC, Durham, NC, Wake Heisler , D. Bilagi and R. G. Rogers . Austin, TX, Madison, WI, Cross Forest, NC, 5Pittsburgh, PA Plains, WI, 4Albany, NY 2:30 pm - 2:40 pm 2:30 pm - 2:40 pm Short Oral 84 - Cost-Effectiveness of Agents Short Oral 117 - Does Intraoperative Bladder Used for Evaluation of Ureteral Patency During Instillation Decrease PACU Recovery Time After Mid- Intraoperative Cystoscopy in Gynecologic and Urethral Sling? A Pilot Study Urogynecologic Surgery L. N. Tholemeier1, F. F. Kanji2, C. Bresee2, E. Choi2, A. L. Ackerman2, M. A. L. Askew. Raleigh, NC, E. Myers. Durham, NC and A. A. Dieter. Chevy Tahery3, J. T. Anger4 and K. S. Eilber2. 1 2 Los Anglees, CA, Los Angeles, CA, Chase, MD 3Glendale, CA, 4Sherman Oaks, CA

PFD Week 2020 19 oCT 8 - 10 Workshops require a separate registration fee. Prsature-Conday,fe rOectoncebe Worr 10kshops Please visit the registration desk to inquire.

1:40 pm - 2:40 pm Session VII Short Oral Session (Microbiome and 3:00 pm - 3:10 pm Preoperative Comorbidities) Introductions Moderators: Peter L. Rosenblatt, MD; Kristin M. Jacobs, MD

1:40 pm - 1:50 pm Short Oral 85 - The Effects of Mindfulness-Based 3:15 pm - 4:15 pm Stress Reduction on the Urinary Microbiome in Patients with Interstitial Cystitis/Bladder Pain Short Oral Session (Sexual) Syndrome Moderators: Ava Leegant, MD; Keith T. Downing, MD A. Shatkin-Margolis1, J. R. White2, A. E. Jedlicka2, A. M. Hill3, T. Tam4, J. Y. Yeung5, C. C. Crisp6 and R. N. Pauls5. 1Dublin, CA, 2Baltimore, MD, 3Blue Ash, OH, 4West chester Township, OH, 5Cincinnati, OH, 6Mason, OH 3:15 pm - 3:25 pm Short Oral 13 - Lower Urinary Tract Symptoms at Age 1:50 pm - 2:00 pm 19: Associations with Sexual Activities Prior to Age 17 Short Oral 86 - Withdrawn B. L. Harlow1, Z. Wang2, H. Chu2, S. Brady2, T. Coyne-Beasley3, C. Fitzgerald4, S. Gahagan5, M. D. Lavender6, J. Lewis7, L. Kane Low8, D. 2:00 pm - 2:10 pm LaCoursiere9, A. Stapleton10, S. Sutcliffe11, A. L. Smith12, J. F. Wyman2 and D. 7 1 2 3 4 Short Oral 87 - Impacts of Estrogen on the Microbial Camenga . Boston, MA, Minneapolis, MN, Birmingham, AL, Maywood, IL, 5 6 7 8 9 Diversity and Presence of Lactobacillus in the San Diego, CA, Chicago, IL, New Haven, CT, Ann Arbor, MI, La Jolla, CA, 10 11 12 Vaginal and Urinary Microbiota Seattle, WA, Saint Louis, MO, Philadelphia, PA I. C. Fields, C. Turner, S. Davin, R. Nardos, W. T. Gregory and L. Karstens. Portland, OR 3:25 pm - 3:35 pm Short Oral 14 - Into the Great Unknown: A Qualitative 2:10 pm - 2:20 pm Study of Women’s Experience of Their First Sexual Encounter After Pelvic Organ Prolapse and/or Short Oral 88 - Association Between Hemoglobin A1C Urinary Incontinence Surgery and Complications of Mid-Urethral Sling in Diabetic 1 1 2 1 3 Patients: A Retrospective Cohort Study L. Caldwell , G. E. Halder , G. C. Dunivan , A. B. White , U. Ossai and R. G. Rogers4. 1Austin, TX, 2Albuquerque, NM, 3Houston, TX, 4Albany, NY M. V. Ortega1, M. Bangura1, E. Ayatiafin1, K. James1, C. Mitchell1, M. M. Weinstein2 and E. Von Bargen3. 1Boston, MA, 2Arlington, MA, 3Cambridge, MA 3:35 pm - 3:45 pm Short Oral 15 - Withdrawn 2:20 pm - 2:30 pm 3:45 pm - 3:55 pm Short Oral 89 - Macrophage Dysfunction: The Missing Link Between Diabetes and Increased Risk of Short Oral 16 - Rate and Timing of Intervention Urogynecologic Mesh Complications for Pelvic Floor Disorders Among Breast Cancer R. Liang, M. Zhao, G. E. King, S. D. Abramowitch and P. A. Moalli. Survivors Compared to Matched Controls Pittsburgh, PA J. F. Pennycuff1, G. Zhang2, H. Wang2 and L. A. Richter1. 1Washington, DC, 2Hyattsville, MD 2:30 pm - 2:40 pm 3:55 pm - 4:05 pm Short Oral 90 - Impact of Body Mass Index on Perioperative Complications for Vaginal versus Short Oral 17 - Patient-Reported Outcomes of Sexual Laparoscopic Pelvic Organ Prolapse Surgeries: A Dysfunction Among Breast Cancer Survivors Contemporary Analysis of a National Database. J. F. Pennycuff, K. Graves, F. Yang, T. Lobo, C. McGuire and L. A. Richter. L. A. Maciejko, M. Abd El Aziz, W. R. Perry, J. A. Occhino and C. K. Kisby. Washington, DC Rochester, MN 4:05 pm - 4:15 pm Short Oral 18 - STOMP: Sexual Function Trial of 2:30 pm - 3:35 pm Overactive Bladder: Medication versus PTNS A. Polland1, J. J. Hamner2, D. Arunachalam2, D. S. Dwarica3, A. Gupta4, J. 5 6 7 8 9 Pop in Lobby: Reflections and Takeaways F. Pennycuff , A. D. Tran , E. Tefera , K. V. Meriwether and R. E. Gutman . 1Brooklyn, NY, 2Indianapolis, IN, 3Columbia, MO, 4Louisville, KY, 5Washington, from the Meeting DC, 6NY, NY, 7Hyattsville, MD, 8Albuquerque, NM, 9Bethesda, MD Moderators: Christina Lewicky-Gaupp, MD; Anthony G. Visco, MD; Sangeeta Mahajan, MD

PFD Week 2020 20 oCT 8 - 10 saturday, October 10

3:15 pm - 4:15 pm 3:15 pm - 4:15 pm

Short Oral Session (Imaging) Short Oral Session (Pain) Moderators: Kris Strohbehn, MD; Olga Ramm, MD Moderators: Edgar LeClaire, MD; Uduak U. Andy, MD

3:15 pm - 3:25 pm 3:15 pm - 3:25 pm Short Oral 19 - Ultrasound Evaluation of Mid- Short Oral 25 - Long-term Symptom Changes in Urethral Sling Position: A Potential Predictor of Patients with Urological Chronic Pelvic Pain Outcomes and Adverse Effects Syndrome: The MAPP Extended Follow-up Study E. Ayati1, Z. Ghanbari2, L. Pourali3, P. Bastani4, M. Ayati2 and E. Amini2. 1Bos- C. S. Bradley1, R. Gallop2, S. Sutcliffe3, K. J. Kreder1, H. H. Lai4, Q. Clemens, ton, MA, 2Tehran, Iran (Islamic Republic of), 3Mashhad, Iran (Islamic Republic MD and B. D. Naliboff6. 1Iowa City, IA, 2West Chester, PA, 3Saint Louis, MO, of), 4Tabriz, Iran (Islamic Republic of) 4St Louis, MO, 5Los Angeles, CA

3:25 pm - 3:35 pm 3:25 pm - 3:35 pm Short Oral 20 - Nomogram for Detecting Abnormal Short Oral 26 - Association Between Preoperative Bladder Shapes During Filling Using Abdominal Pain Perceptions and Postoperative Outcomes in a Ultrasound in Women with Overactive Bladder Mixed Inpatient Surgical Cohort A. W. Carroll1, R. Li1, A. S. Nagle2, K. Maddra1, L. Siff1, A. P. Klausner1 and J. M. M. Z. Zheng1, N. A. Koenig1, T. Lee1, M. Larouche2 and R. Geoffrion3. E. Speich1. 1Richmond, VA, 2Fort Wayne, IN 1Vancouver, BC, Canada, 2Dorval, QC, Canada, 3West Vancouver, BC, Canada

3:35 pm - 3:45 pm 3:35 pm - 3:45 pm Short Oral 21 - Role of Dynamic Endovaginal Short Oral 27 - Small Fiber Polyneuropathy is a Ultrasound in Stress Urinary Continence Assessment Common Finding in Non-Bladder Centric Interstitial M. R. Routzong1, C. Chang2, R. P. Goldberg3, S. D. Abramowitch1 and G. Cystitis/Bladder Pain Syndrome Patients Rostami Nia4. 1Pittsburgh, PA, 2Evanston, IL, 3Skokie, IL, 4Chicago, IL T. L. Overholt1, C. A. Matthews1, R. J. Evans2, G. Badlani3, C. Ahn1, T. Simon1 and S. Walker3. 1Winston-Salem, NC, 2Winston-salem, NC, 3Winston Salem, 3:45 pm - 3:55 pm NC Short Oral 22 - Resting Genital Hiatus and Ligament 3:45 pm - 3:55 pm Length Have a Threshold Effect on Prolapse Size and Apical Tension: Simulation Results from POP-SIM Short Oral 28 - Relationship of Pain Catastrophizing Biomechanical Model with Urinary Biomarker of Brain Function in Women M. T. Gordon1, J. O. L. DeLancey2, C. W. Swenson2, J. A. Ashton-Miller2 and with Bladder Pain Syndrome L. Chen2. 1Riverside, CA, 2Ann Arbor, MI A. J. Soriano1, A. Malykhina2, U. U. Andy1 and L. A. Arya1. 1Philadelphia, PA, 2Aurora, CO 3:55 pm - 4:05 pm 3:55 pm - 4:05 pm Short Oral 23 - Changes in Cardinal Ligament Length and Curvature with Parity and Prolapse and Their Short Oral 29 - Predicting Improvement in Pain Relation to Hiatus and Pelvic Floor Status Following Transvaginal Mesh Removal W. Cheng, M. E. Duarte Thibault, L. Chen, J. O. L. DeLancey and C. W. S. M. Glass Clark, A. M. Artsen, L. Meyn, P. A. Moalli and M. S. Bradley. Swenson. Ann Arbor, MI Pittsburgh, PA

4:05 pm - 4:15 pm 4:05 pm - 4:15 pm Short Oral 24 - Perineal Membrane Structural Short Oral 30 - Role of Systemic and Regional Changes with Prolapse Among Women with Intact Inflammation: Peripheral Blood Counts and a History Levator Ani Muscles of Endometriosis in Mesh Complications L. Chen, J. O. L. DeLancey and C. W. Swenson. Ann Arbor, MI A. M. Artsen, C. Layding, L. Meyn, S. D. Abramowitch and P. A. Moalli. Pittsburgh, PA

PFD Week 2020 21 oCT 8 - 10 saturday, October 10

3:15 pm - 4:15 pm 3:25 pm - 3:35 pm Short Oral 50 - Decreasing Rates of Symptomatic Short Oral Session (Epidemiology) Urinary Tract Infections After Pelvic Reconstructive Surgery: A Quality Improvement Analysis Moderators: Tanaz Ferzandi, MD, MS, CPE; Kate V. Meriwether, MD M. E. Duarte Thibault, L. P. Burns, A. M. Tilea, K. A. Piehl, C. W. Swenson, D. E. Fenner and D. M. Morgan. Ann Arbor, MI 3:15 pm - 3:25 pm Short Oral 37 - Machine Learning Model for 3:35 pm - 3:45 pm Complicated Delivery and Pelvic Floor Injury Short Oral 51 - The Impact of Mid-Urethral Sling , S. D. Abramowitch, E. Sejdic and P. A. Moalli. L. S. Burkett Pittsburgh, PA Surgery on the Development of Urinary Tract Infections 3:25 pm - 3:35 pm A. Berger, J. Tan-Kim and S. Menefee. San Diego, CA Short Oral 38 - Updating the Prevalence of Urinary Incontinence in Adult Women Using 2015-2016 Data 3:45 pm - 3:55 pm from a National Population-Based Survey Short Oral 52 - Antibiotic Regimen and Route of , A. L. Godecker, D. L. Giles and H. W. Brown. U. J. Patel Madison, WI Administration Do Not Alter Rates of Urinary Tract Infection After Intravesical OnabotulinumtoxinA 3:35 pm - 3:45 pm Injection for Overactive Bladder Short Oral 39 - Urogynecologic Surgery from 2008 S. E. Eckhardt1, Y. Bean2, S. J. Handler1, C. F. Tenggardjaja3 and T. Yazdany1. through 2018: Examining Trends in Apical Prolapse 1Torrance, CA, 2Irvine, CA, 3Cleveland, OH Repair, Incontinence Surgery and Mesh Utilization Using the NSQIP Database 3:55 pm - 4:05 pm A. A. Dieter. Chevy Chase, MD, K. Moore. Minneapolis, MN, M. G. Willis- Short Oral 53 - Recurrent Urinary Tract Infection: Gray. , C. B. Iglesia. , R. E. Gutman. Durham, NC Washington, DC Bethesda, Comparison of Sample Collection and Culture MD and E. T. Carey. Chapel Hill, NC Methods B. R. Hochstedler1, L. A. Burnett2, L. Brubaker3 and A. J. Wolfe1. 1Maywood, 3:45 pm - 3:55 pm IL, 2San Diego, CA, 3Rancho Santa Fe, CA Short Oral 40 - National Trends in Uterine Preserving Reconstructive Procedures: 4:05 pm - 4:15 pm Hysterectomy versus Hysteropexy at the Time of Short Oral 54 - Biofilm Production by Uropathogens Apical Suspension in Postmenopausal Women with Recurrent and 1, E. Tunitsky2 and R. Wang1. 1 2 A. S. Ramaseshan Hartford, CT, West Isolated UTI Hartford, CT K. Falk, G. M. Northington, F. Chassagne, S. Satola and C. Quave. Atlanta, GA 3:55 pm - 4:05 pm Short Oral 41 - Supplementing Questionnaire Data with a Simple Self-Administered Objective Test for 3:15 pm - 4:15 pm Higher Precision in Classifying Type of Incontinence J. M. Miller and S. D. Harlow. Ann Arbor, MI Short Oral Session (Basic Science) Moderators: Maria Florian Rodriguez, MD; Marsha Guess, MD 4:05 pm - 4:15 pm Short Oral 42 - Overactive Bladder Medication 3:15 pm - 3:25 pm Prescription Trends from 2014-2018 Short Oral 55 - Characterizing the Mechanical A. A. Sripad, C. Raker, T. I. Shireman and V. W. Sung. Providence, RI Behavior of Polycarbonate Urethane – A Potential Alternative Polymer for Prolapse Meshes K. M. Knight1, E. O. Bachtiar2, K. Gall2, S. D. Abramowitch1 and P. A. Moalli1. 3:15 pm - 4:15 pm 1Pittsburgh, PA, 2Durham, NC

Short Oral Session (UTI) 3:25 pm - 3:35 pm Short Oral 56 - Utilization of Purified Exosome Moderators: Dobie Giles, MD; Saifuddin T. Mama, MD, MPH Product as a Novel, Cell-Free Regenerative Platform for Skeletal Muscle Regeneration 3:15 pm - 3:25 pm E. C. Trabuco, T. Rolland, R. Takhter, P. Stalboerger, A. Behfar and S. Short Oral 49 - A Randomized Trial Comparing Boroumand. Rochester, MN Methenamine Hippurate to Trimethoprim for the Prevention of Recurrent Urinary Tract Infections C. Botros1, S. Lozo2, S. Iyer3, A. Warren4, R. P. Goldberg5, J. E. Tomezsko5, K. C. Sasso6, P. K. Sand7, A. Gafni-Kane3, A. Biener1 and S. Botros-Brey8. 1Easton, PA, 2NY, NY, 3Chicago, IL, 4Buffalo Grove, IL, 5Skokie, IL, 6Highland Park, IL, 7Winnetka, IL, 8San Antonio, TX

PFD Week 2020 22 oCT 8 - 10 saturday, October 10

3:35 pm - 3:45 pm 3:45 pm - 3:55 pm Short Oral 57 - Evaluation of a Fully Absorbable Short Oral 94 - Preoperative Counseling Method and Poly-4-Hydroxybutyrate (P4HB) Scaffold for Pelvic Postoperative Opioid Usage: A Secondary Analysis of Organ Prolapse (POP) at 12 months Following the Patient Preparedness Randomized Controlled Implantation in an Ovine Model Trial Z. Guler1, E. Vodegel2, L. Kaestner3, L. Ras4, S. Jeffery3 and J. P. Roovers5. J. C. Sassani1, A. M. Artsen1, L. Baranski1, L. Kunkle and M. F. Ackenbom1. 1Amsterdam, Netherlands, 2Amsterdam, NH, Netherlands, 3Cape Town, 1Pittsburgh, PA WC, South Africa, 4Cape Town, South Africa, 5Amsterdam, Noord Holland, Netherlands 3:55 pm - 4:05 pm 3:45 pm - 3:55 pm Short Oral 95 - Post-Operative Lower Extremity Neuropathy in Gynecologic Surgery with Boot and Short Oral 58 - Evidence of Metabolic Endotoxemia Candy Cane Stirrups as a Potential Risk Factor for Pelvic Organ Prolapse A. Whitis, E. Chen, M. Sekhon, S. Akella, C. S. Bradley and J. T. Kowalski. J. Johnson1, D. Orlicky1, L. G. Rascoff2, J. Hutchinson-Colas3, J. S. Arruda1, Iowa City, IA E. C. Bales1, M. K. Guess1 and K. A. Connell1. 1Aurora, CO, 2Denver, CO, 3 New Brunswick, NJ 4:05 pm - 4:15 pm 3:55 pm - 4:05 pm Short Oral 96 - Postoperative Pain After Sacrospinous Ligament Colpopexy Versus Short Oral 59 - Human Vaginal Fibroblasts Undergo Hysteropexy Cellular Senescence and Respond to Senolytics A. S. Yuan1, K. Propst2 and C. A. Ferrando2. 1Shaker Heights, OH, 2Cleveland, M. E. Florian Rodriguez, A. M. Hare, K. Yau, N. G. Gaddam, H. Shi, P. W. OH Keller and R. A. Word. Dallas, TX

4:05 pm - 4:15 pm 3:15 pm - 4:15 pm Short Oral 60 - Dysregulated Wound Healing: A Plausible Mechanism Leading to Mesh Complications Short Oral Session (Surgical Education/ A. M. Artsen, R. Liang, L. Meyn, N. M. Pace, S. D. Abramowitch and P. A. Moalli. Pittsburgh, PA Hysterectomy/Hysteropexy) Moderators: AnnaMarie Connolly, MD; Kyle J. Wohlrab, MD

3:15 pm - 4:15 pm 3:15 pm - 3:25 pm Short Oral 97 - A Novel Resident Robotic Curriculum Short Oral Session (Opioid Use and Postop Using Self-Selection for Advanced Training and a Single Web-Based Tool for Feedback and Case- Pain) Tracking Moderators: Kimberly Ferrante, MD; Bhumy A. Heliker, MD A. L. Merriman1, M. E. Tarr2, K. R. Kasten1 and E. M. Myers1. 1Charlotte, NC, 2Concord, NC 3:15 pm - 3:25 pm Short Oral 91 - Randomized Controlled Trial 3:25 pm - 3:35 pm Assessing the Impact of Opioid-Specific Counseling Short Oral 98 - Assessing The Impact Of Vaginal on Opioid Consumption and Disposal After Hysterectomy With Vaginal Mesh Attachment On Urogynecologic Surgery Outcomes And Complications During Minimally K. Buono1, E. L. Whitcomb2, N. M. Guaderrama3, E. Lee4, J. Ihara5, N. T. Su- Invasive Sacrocolpopexy dol5, F. L. Lane4, J. K. Lee5, B. D. Heliker4 and T. J. Brueseke. 1Sacramento, K. L. Woodburn1, S. E. Bradley2, S. A. Ward1, K. A. Schirm1, B. Clarke1, M. CA, 2Newport Beach, CA, 3Dana Point, CA, 4Orange, CA, 5Anaheim, CA Jonikas1, R. E. Gutman3 and A. I. Sokol1. 1Washington, DC, 2Asheville, NC, 3Bethesda, MD 3:25 pm - 3:35 pm Short Oral 92 - Age and Postoperative Opioid Use in 3:35 pm - 3:45 pm the Urogynecology Population Short Oral 99 - Vaginal Hysterectomy Rates M. G. Willis-Gray1, H. G. Leazer2, S. V. Sun2, K. Feliciano2, A. A. Dieter3, E. J. Before and After Implementation of a Multi-Tier Geller2, A. Connolly2, B. A. Chidgey2 and J. M. Wu2. 1Apex, NC, 2Chapel Hill, Intervention to Increase Vaginal Hysterectomy NC, 3Chevy Chase, MD Performance at a Teaching Hospital T. Crouss1, S. Sharma1, D. Smith2, K. Hunter2 and L. Lipetskaia3. 3:35 pm - 3:45 pm 1Philadelphia, PA, 2Camden, NJ, 3Cooper University, Camden, NJ Short Oral 93 - A Retrospective Chart Review: Effect of Regional versus General Anesthesia on 3:45 pm - 3:55 pm Postoperative Urogynecologic Pain Short Oral 100 - Differences in Morbidity and C. E. Savilo. Chandler, AZ, R. R. Stratford. Mesa, AZ, K. L. Kantartzis. Tempe, Surgical Outcomes for Concomitant Hysterectomy AZ and R. D. Gerkin. Phoenix, AZ versus Staged Hysterectomy and Gender Affirmation Surgery in Transgender Men B. Ha1, E. Weiss1, D. Stram2 and M. Y. Morrill1. 1San Francisco, CA, 2Oakland, CA

PFD Week 2020 23 oCT 8 - 10 saturday, October 10

3:55 pm - 4:05 pm 4:15 pm - 4:25 pm Short Oral 101 - Healthcare Utilization Trends Short Oral 109 - Effects of an Enhanced Recovery Following Minimally Invasive Apical Suspension in a after Surgery Protocol in Women Undergoing Apical Large Integrated Healthcare System Prolapse Repair B. Ha1, T. S. Pratt2, M. Merchant and O. Ramm2. 1San Francisco, CA, S. P. Desai, K. S. Williams, T. W. Muir and D. D. Antosh. Houston, TX 2Oakland, CA 4:25 pm - 4:35 pm 4:05 pm - 4:15 pm Short Oral 110 - Is the Modified Frailty Index Short Oral 102 - Perioperative and Postoperative Predictive of Perioperative Complications in Women Outcomes of Colpocleisis: A Case Series From a Single Undergoing Benign Hysterectomy? Institution D. Luchristt1, M. Luck2, O. Brown2, J. Geynisman-Tan2, C. Lewicky-Gaupp3 and L. Jammallo1, D. Maheshwari2, O. Harmanli3, N. Diaz4, V. Rastegar4 and K. C. E. Bretschneider4. 1Durham, NC, 2Chicago, IL, 3Winnetka, IL, 4Winfield, OH Jones4. 1Ludlow, MA, 2Worcester, MA, 3Shelton, CT, 4Springfield, MA

3:15 pm - 4:15 pm 3:15 pm - 4:15 pm Short Oral Session (Anatomy) Short Oral Session (Same Day Discharge and Moderators: Nicole Korbly, MD; Kristie A. Greene, MD Perioperative Complications) Moderators: Jennifer Thompson, MD; Pamela J. Levin, MD 3:15 pm - 3:25 pm Short Oral 111 - Intraoperative and Immediate 3:15 pm - 3:25 pm Postoperative Changes to Genital Hiatus Following Short Oral 103 - Enhanced Recovery After Surgery Minimally Invasive Sacrocolpopexy Protocols: Does it Improve Patient Perceived S. M. Glass Clark, J. C. Sassani, H. M. Zyczynski and M. S. Bradley. Postdischarge Recovery After Laparoscopic Pittsburgh, PA Sacrocolpopexy? C. Pan and M. Heit. Indianapolis, IN 3:25 pm - 3:35 pm Short Oral 112 - Association Between Levator Plate 3:25 pm - 3:35 pm Shape and Long-Term Surgical Outcomes Following Short Oral 104 - Success of Planned Same Day Native Tissue Prolapse Repair: A Principal Component Discharge Following Reconstructive Surgery for Analysis Pelvic Organ Prolapse M. T. Gordon1, C. W. Swenson2, P. Schmidt2, J. O. L. DeLancey2 and L. Chen2. 1 2 D. Hernandez-Aranda1, D. J. Sanderson2 and J. N. Byrnes1. 1Rochester, NY, Riverside, CA, Ann Arbor, MI 2Rochester, MN 3:35 pm - 3:45 pm 3:35 pm - 3:45 pm Short Oral 113 - Age, Parity and Prolapse: Interaction Short Oral 105 - Timing and Characterization of and Influence on Levator Bowl Volume Readmission and Reoperation Following Operative W. Cheng, L. Chen, J. O. L. DeLancey and C. W. Swenson. Ann Arbor, MI Colpopexy N. G. Gaddam1, G. S. Yadav2 and D. D. Rahn1. 1Dallas, TX, 2Houston, TX 3:45 pm - 3:55 pm Short Oral 114 - Pelvic Structure as a Risk Factor for 3:45 pm - 3:55 pm Pelvic Organ Prolapse Short Oral 106 - Length of Stay and 30-Day C. Cipparone1, A. DeRosa1, J. Shelton1, K. Benson1, V. Gosy1, E. Piccillo1, A. Postoperative Complications Following Minimally Stoklosa1 and T. S. Ablove2. 1Buffalo, NY, 2Clarence Center, NY Invasive Apical Prolapse Repair A. A. Dieter. Chevy Chase, MD, K. Moore. Minneapolis, MN, M. G. Willis- 3:55 pm - 4:05 pm Gray. Durham, NC, R. E. Gutman. Bethesda, MD, C. B. Iglesia. Washington, Short Oral 115 - Quantifying Pelvic Floor Muscle and E. T. Carey. DC Chapel Hill, NC Fascicle Orientations for Computational Applications M. R. Routzong1, M. S. Cook2, W. Barone3, S. D. Abramowitch1 and M. 3:55 pm - 4:05 pm Alperin4. 1Pittsburgh, PA, 2Minneapolis, MN, 3Indianola, PA, 4La Jolla, CA Short Oral 107 - Patient Reported Outcomes and Satisfaction in an Enhanced Recovery after Surgery 4:05 pm - 4:15 pm Protocol in Urogynecology Short Oral 116 - Volumetric Differences in Cortical S. P. Desai, K. S. Williams, T. W. Muir and D. D. Antosh. Houston, TX & Sub-Cortical Structures in Anti-Cholinergic Responders & Non-Responders 4:05 pm - 4:15 pm N. Martin, J. Prescott, L. Walden, J. Mangel, A. Hijaz and D. Sheyn. Cleveland, Short Oral 108 - Effects of an ERAS Protocol on OH Outpatient Opioid Use in Apical Prolapse Surgery S. P. Desai, K. S. Williams, T. W. Muir and D. D. Antosh. Houston, TX

PFD Week 2020 24 oCT 8 - 10 award recipients au g s award JACK ROBERTSON LIFETIME PFD WEEK ABSTRACT AWARD WINNERS ACHIEVEMENT AWARD Best Overall Paper Ingrid Nygaard, MD CONCOMITANT RETROPUBIC MIDURETHRAL SLING AND University of Utah Health Sciences Center ONABOTULINUMTOXINA INJECTIONS ARE A SAFE TREATMENT r e cipi nts OPTION FOR MIXED URINARY INCONTINENCE AUGS’ most prestigious award is presented Author: Alix Komar, MD; Northwestern University periodically to an individual who has had a lifetime of outstanding achievements in the field of Female Pelvic Best Clinical Paper Medicine and Reconstructive Surgery and has served as a SUCCESS AND FAILURE ARE DYNAMIC, RECURRENT EVENT role model through service, basic or clinical research and STATES THAT ALTERNATE AFTER SURGICAL TREATMENT FOR teaching. PELVIC ORGAN PROLAPSE Author: J. Eric Jelovsek, MD, MMEd, MSDS; Duke University Medical

Center RAYMOND A. LEE ENDOWMENT Dee E. Fenner, MD Best Video University of Michigan LAPAROSCOPIC REPAIR OF PERSISTENT VESICOVAGINAL FISTULA: IMPORTANCE OF PROPER IDENTIFICATION IN CASES OF RECURRENCE Author: Tara Marczak, DO; Mount Auburn Hospital/Beth Israel The Raymond A. Lee Endowment is a named lectureship Deaconess Medical Center created by AUGS to honor one person annually who contributed to the development and surgical advancement Best Basic Science Paper of urogynecology and to further advance the knowledge UNDERSTANDING THE IN VIVO IMPACT OF PORE GEOMETRY ON and teaching of gynecologic surgery through ongoing AUGS THE BIOMECHANICAL PROPERTIES OF THE VAGINA educational programs. Author: Katrina Knight, PhD; Magee-Women’s Research Institute Dr. Fenner will present Advancing Women and Underrepresented Minorities in OBGYN. Basic Science PhD Award VAGINAL ANGULATION AFTER VAGINAL HYSTERECTOMY

WITH UTEROSACRAL LIGAMENT SUSPENSION OR VAGINAL AUGS Innovation Lectureship Award MESH HYSTEROPEXY: INVESTIGATING THE ROLE OF VAGINAL CONFIGURATION IN ANATOMIC FAILURE OF APICAL PROLAPSE REPAIR J. Eric Jelovsek, MD, MMEd, MSDS Author: Shaniel Bowen, PhD; University of Pittsburgh Duke University School of Medicine Best Urogynecology Fellow Paper

HOME BIOFEEDBACK VERSUS PELVIC FLOOR PHYSICAL The AUGS Innovation Lectureship Award honors an individual THERAPY FOR STRESS URINARY INCONTINENCE: A RANDOMIZED, who has demonstrated innovation in urogynecology, specif- NON-INFERIORITY TRIAL Author: ically demonstrating excellence in the development of new Lauren Barnes, MD; University of New Mexico techniques (including diagnostic techniques), technology, out- come measures, educational initiatives, product development Best Resident Paper or other activities that support the goals of this Lectureship. OUTCOMES FOLLOWING TOTAL VAGINAL HYSTERECTOMY WITH UTEROSACRAL LIGAMENT SUSPENSION COMPARED TO Dr. Jelovsek will present Clinical Prediction Models, Machine SUPRACERVICAL HYSTERECTOMY WITH SACROCERVICOPEXY FOR Learning and Decision-making. THE MANAGEMENT OF UTEROVAGINAL PROLAPSE Author: Alexandra Melnyk, MD, Med; Magee-Women’s Hospital of the University of Pittsburgh

PFD Week 2020 25 oCT 8 - 10 award recipients (continued) pfd r e s arc h foundation ROBIN HAFF RESEARCH AWARD FPMRS Journal Awards Mary Tulke, RN 2020 Top Reviewers Award Loyola University Medical Center Heidi W. Brown, MD Megan Bradley, MD This award is presented annually to an individual in recognition of outstanding and sustained contribution Oz Harmanli, MD to female pelvic floor disorders research. The Robin Haff Research Peter C. Jeppson, MD Award recognizes the important role that clinical research nurses and James Whiteside, MD, MA research coordinators play in the clinical research process. Without Anthony Visco, MD dedicated and committed research staff, high quality research would Lauren Siff, MD award r e cipi nts not be possible. Sunil Balgobin, MD Johnny Yi, MD PFD RESEARCH FOUNDATION DONOR OF THE YEAR AWARD Cedric Olivera, MD, MS Margie Kahn, MD Tulane University School of Medicine 2020 Top-Cited Article Award Emad Matanes, MD The PFD Research Foundation presents the Donor of the Single Port Robotic Assisted Sacrocolpopexy: Year Award to an individual in recognition of commitment Our Experience with the First 25 Cases to the Foundation’s mission of transforming the lives of women through the support of innovative and effective research that advances the 2020 Media Impact Award prevention, treatment, and cure of female pelvic floor disorders. Cecilia K. Wieslander, MD Pregnancy in Women with Prior Treatments PFD RESEARCH FOUNDATION for Pelvic Floor Disorders GRANT RECIPIENTS PFD RESEARCH FOUNDATION FELLOW RESEARCH AWARD Megan S. Bradley, MD Magee-Women’s Hospital of UPMC A Qualitative Study of Postmenopausal Women’s Decision-making and Knowledge Gaps Surrounding Bacteriuria

PFD RESEARCH FOUNDATION FELLOW RESEARCH AWARD Shailja Mehta, MD Yale University Targeting Urinary Tract Infections Using Non-Antibiotic Substances

JUNE ALLYSON MEMORIAL FUND RESEARCH AWARD Lindsey Ann Burnett, MD, University of California - San Diego Temporal Molecular and Structural Alterations in the Intramuscular Extracellular Matrix Across Gestation and Their Impact on Muscle Stem Cell Function

PFD Week 2020 26 oCT 8 - 10 Workshops require a separate registration fee. Pre-ConferenAUGS Leadershipce Workshops Please visit the registration desk to inquire. au g s le ad e rs h ip 2019-2020 Board of Directors Directors-at-Large Past Presidents President Tanaz R. Ferzandi, MD, MBA American Urogynecologic Society Shawn A. Menefee, MD Keck School of Medicine Geoffrey W. Cundiff, MD, FACOG, FACS, FRCSC Kaiser Permanente, San Diego at USC Charles R. Rardin, MD, FACOG, FACS (2017-2018) Halina Zyczynski, MD (2016-2017) Douglass S. Hale, MD (2015-2016) Amy Rosenman, MD (2014-2015) Margaret Mueller, MD Charles Nager, MD (2013-2014) Northwestern University Anthony Visco, MD (2012-2013) Feinberg School of Medicine Matthew Barber, MD, MHS (2011-2012) Deborah Myers, MD (2010-2011) President Elect Rebecca Rogers, MD (2009-2010) Holly Richter, PhD, MD Dee Fenner, MD (2008-2009) University of Alabama at Lieschen H. Quiroz, MD Kris Strohbehn, MD (2007-2008) Ingrid Nygaard, MD (2006-2007) Birmingham Oklahoma University Health Joseph Montella, MD (2005-2006) Sciences Center Stephen Young, MD (2004-2005) Michael Aronson, MD (2003-2004) Linda Brubaker, MD (2002-2003) Peggy Norton, MD (2001-2002) David D. Rahn, MD W. Conrad Sweeting, MD (2000-2001) Vice President UT Southwestern Nicolette Horbach, MD (1999-2000) Elizabeth R. Mueller, MD Mickey Karram, MD (1998-1999) Richard Bump, MD (1997-1998) Loyola Medicine Stritch Bob Shull, MD (1996-1997) School of Medicine John O. L. DeLancey, MD (1995-1996) Eric R. Sokol, MD Alfred Bent, MD (1994-1995) Stanford University John Higgins, MD (1993-1994) Charles deProsse (1992-1993) School of Medicine J. Thomas Benson (1991-1992) David A. Richardson (1990-1991) Treasurer Ernest I. Kohorn (1989-1990) Michael K. Flynn, MD, MS Elisa R. Trowbridge, MD Henry A. Thiede (1988-1989) Richard O. Davis, MD (1987-1988) University of Massachusetts University of Virginia J. Andrew Fantl, MD (1986-1987)

Gynecologic Urology Society R. Peter Beck, MD (1985-1986) Donald R. Ostergard, MD (1984-1985) PFD Research Foundation Chair Douglas J. Marchant, MD (1983-1984) W. Glenn Hurt, MD (1982-1983) Immediate Past President Christopher M. Tarnay, MD Hugh M. Shingleton, MD (1981-1982) Geoffrey W. Cundiff, MD, UCLA School of Medicine C. Paul Hodgkinson, MD (1980-1981) FACOG, FACS, FRCSC Jack R. Robertson, MD (1979-1980) University of British Columbia AUGS Staff Michelle Zinnert, CAE, Chief Executive Officer PFD Research Foundation Vice Chair Colleen Hughes, Chief Operating Officer Elizabeth Geller, MD Nicole Cranston, MS, Senior Director of Education University of North Carolina Programs Karen Richards, Senior Director of Quality and Research Veronica Valderrama, Publications Director Tristan Wood, Director of Marketing and Mem- Ex-Officio Members bership AUGS Executive Director Galen Conti, Research Manager Funmi Yusuf, Senior Coordinator, Education Michelle Zinnert, CAE Programs American Urogynecologic Gabriell Maupin, Marketing and Membership Society Coordinator Crystal Adams, Executive Assistant ABOG Representative Vanessa Clemens, Membership and Events Assistant Marlene Corton, MD, MS UT Southwestern Medical Center

PFD Week 2020 27 oCT 8 - 10 Workshops require a separate registration fee. InvPre-Conferenited speakecre DWorkshoisclosurpes gu ide Please visit the registration desk to inquire.

Ackerman, A. Lenore, MD, PhD Ferzandi, Tanaz R., MD, MBA LaSala, Christine A., MD Park, Amy, MD No relevant financial relationships No relevant financial relationships No relevant financial relationships Allergan: Speakers’ Bureau to disclose. to disclose. to disclose. Parker-Autry, Candace Y., MD Alperin, Marianna, MD, MS Florian Rodriguez, Maria E., MD LeClaire, Edgar L., MD, MS No relevant financial relationships No relevant financial relationships No relevant financial relationships No relevant financial relationships to disclose. to disclose. to disclose. to disclose. Pulliam, Samantha J., MD Anand, Mallika, MD, MS Giles, Dobie L, MD, MS Leegant, Ava, MD Renovia Inc: Other Financial or No relevant financial relationships No relevant financial relationships No relevant financial relationships Material Support to disclose. to disclose. to disclose. Quiroz, Lieschen H., MD Antosh, Danielle D, MD Glazier, David, MD Mama, Saifuddin T., MD, MPH BK Medical: Other Financial or No relevant financial relationships Allergan plc: Other Financial or No relevant financial relationships Material Support to disclose. Material Support to disclose. Cook: Grant/Research Support Renovia: Grant/Research Support Barber, Matthew D., MD, MHS Goldberg, Roger P, MD, MPH Matthews, Catherine A., MD UptoDate: Other Financial or Elsevier: Other Financial or No relevant financial relationships Boston Scientific: Consultant, Material Support Material Support to disclose. Grant/Research Support UpToDate: Other Financial or Grimes, Cara L., MD, MAS Johnson and Johnson: Other Rahn, David D., MD Material Support Johnson and Johnson: Other Financial or Material Support No relevant financial relationships Neomedic: Grant/Research to disclose. Barker, Matthew A., MD, FACOG Financial or Material Support Support Astellas: Speakers’ Bureau Guess, Marsha K K., MD Rardin, Charles R., MD, FACOG, FACS Blomquist, Joan L., MD No relevant financial relationships Meriwether, Kate V., MD Foundation for Female Health No relevant financial relationships to disclose. Elsevier Publishing: Other Financial Awareness: Grant/Research to disclose. or Material Support Gurland, Brooke, MD RBI Medical: Consultant Support Bridges, Khiara M., JD Medtronics: Speakers’ Bureau Society of Gynecologic Surgeons: NICHD - Pelvic Floor Disorders No relevant financial relationships Gutman, Robert E., MD Other Financial or Material Network: Grant/Research Support to disclose. Boston Scientific: Consultant, Support Pelvalon, Inc: Grant/Research Brown, Heidi W, MD, MAS Grant/Research Support Mueller, Margaret G, MD Support No relevant financial relationships Johnson & Johnson: Other Axonics: Consultant Solace Therapeutics: Grant/ to disclose. Financial or Material Support Research Support Muffly, Tyler M, MD, FACS Brubaker, Linda, MD, MS Up To Date: Other Financial or Richter, Holly E., PhD, MD Material Support No relevant financial relationships FPMRS: Other Financial or Material to disclose. No relevant financial relationships Support Haefner, Hope, MD to disclose. Murphy, Miles, MD, MSPH JAMA: Other Financial or Material No relevant financial relationships Rickey, Leslie, MD, MPH Support to disclose. No relevant financial relationships to disclose. Renovia Inc: Consultant NIH: Grant/Research Support Hampton, Brittany Star, MD UpToDate: Other Financial or Up To Date: Other Financial or No relevant financial relationships Nihira, Mikio A., MD, MPH Material Support Material Support to disclose. Boston Scientific: Consultant UroCure: Consultant Ethicon: Consultant Brueseke, Taylor John, MD Harmanli, Oz, MD HealthTrust: Consultant Rosenblatt, Peter L., MD No relevant financial relationships No relevant financial relationships Boston Scientific: Consultant, to disclose. Hologic: Consultant to disclose. Pacira: Consultant Grant/Research Support, Other Carberry, Cassandra, MD, MS Surgical Pain Consortium: Other Financial or Material Support Harvie, Heidi S, MD, MSCE, MBA C.R. Bard: Other Financial or No relevant financial relationships No relevant financial relationships Financial or Material Support to disclose. Material Support to disclose. Ninivaggio, Cara S, MD Coloplast: Consultant Chung, Christopher P, MD Iglesia, Cheryl B., MD Cook MyoSite: Grant/Research CooperSurgical: Consultant No relevant financial relationships No relevant financial relationships Support Ethicon: Other Financial or Material to disclose. to disclose. Northington, Gina M., MD, PhD Support DeLancey, John O. L., MD No relevant financial relationships Hologic: Consultant Komesu, Yuko M., MD Medtronic: Consultant Proctor and Gamble: Grant/ Cook Myosite: Grant/Research to disclose. Research Support Tepha: Consultant Support Occhino, John A., MD, MS Downing, Keith T., MD NIDDK: for the Pelvic Floor No relevant financial relationships Rosenman, Amy E., MD No relevant financial relationships Disorders Network: Grant/ to disclose. No relevant financial relationships to disclose. Research Support to disclose. Orejuela, Francisco, MD, MS Dutta, Sonia, MD Korbly, Nicole B., MD No relevant financial relationships Schaffer, Joseph, MD No relevant financial relationships No relevant financial relationships to disclose. Boston Scientific: Grant/Research to disclose. to disclose. Support Ossai, Uchenna, PT, DPT, WCS McGraw-Hill Publishing: Other Ferrando, Cecile A., MD, MPH Lane, Felicia L., MD No relevant financial relationships Financial or Material Support UpToDate, Inc: Other Financial or Axonics: Grant/Research Support to disclose. Material Support

PFD Week 2020 28 oCT 8 - 10 Invited speaker Disclosure guide

Schimpf, Megan O, MD Sokol, Eric R., MD Sung, Vivian W., MD, MPH Wu, Jennifer M., MD, MPH No relevant financial relationships Coloplast: Grant/Research Support No relevant financial relationships No relevant financial relationships to disclose. Cook MyoSite: Grant/Research to disclose. to disclose. Schuster, Mitchell W., MD Support Thompson, Jennifer, MD Yazdany, Tajnoos, MD No relevant financial relationships Cynosure: Grant/Research Support No relevant financial relationships No relevant financial relationships to disclose. FFHA: Grant/Research Support to disclose. to disclose. NIH: Grant/Research Support Segal, Saya, MD, MSCE, FACOG Pelvalon: Other Financial or Washington, Blair B., MD MHA No relevant financial relationships Material Support No relevant financial relationships to disclose. to disclose. Stratford, Ryan R., MD, MBA Shepherd, Jonathan P., MD, MSc. No relevant financial relationships White, Amanda B., MD No relevant financial relationships to disclose. No relevant financial relationships to disclose. to disclose. Strohbehn, Kris, MD Sokol, Andrew I., MD Medscape eMedicine: Other Wohlrab, Kyle J., MD Butler Snow: Other Financial or Financial or Material Support No relevant financial relationships Material Support Reia: Grant/Research Support to disclose.

PFD Week 2020 29 oCT 8 - 10 Stay tuned for all the exciting educational opportunities AUGS will be offering in late 2020 and throughout 2021!

AUGS at Home Workshop Series November 21 – 22, 2020 Virtual Meeting - Registration open now

Fundamentals of Urogynecology January 21 – 22, 2021 Virtual Meeting - Registration opens October 26, 2020

Clinical Meeting April 22-24, 2021 Marina Del Rey, California

Urogynecologic Master Class June 10-13, 2021 Tampa, Florida

Urogynecology for the Advanced Practice Provider June 2021 Nashville, Tennessee - Abstract submission opens October 15, 2020

For more information, visit www.augs.org/education/courses.

PFD Week 2020 30 oCT 8 - 10 PFDWEEK2021 MONTREAL

Save the Date OCTOBER 5-9, 2021 \ MONTREAL, CANADA www.pfdweek.org

PFD Week 2020 31 oCT 8 - 10